Abnormal weight loss

R18_ABNORMAL_WEIGHT_LOSS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R63.4 Hospital discharge: ICD-9 — 7832 Hospital discharge: ICD-8 — 78840 Cause of death: ICD-10 — R63.4 Cause of death: ICD-9 — 7832 Cause of death: ICD-8 — 78840 2 out of 7 registries used, show all original rules.	4392
4. Check minimum number of events None	4392
5. Include endpoints None	4392
6. Filter based on genotype QC (FinnGen only)	3958

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF5

NAME	R18_ABNORMAL_WEIGHT_LOSS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R634
HD_ICD_9	7832
HD_ICD_8	78840
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R634
COD_ICD_9	7832
COD_ICD_8	78840
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Abnormal weight loss based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3958	2155	1803
Unadjusted period prevalence (%)	0.79	0.77	0.83
Median age at first event (years)	66.72	64.38	69.53

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4096: Matched controls
40960

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

5.2

307.7

2363

8551

R63.4

ICD-10 Finland

Abnormal weight loss

7714.1

307.7

4057

545

T08

ICPC

Weight loss

9.2

238.0

298

346

UJF32

NOMESCO Finland

Coloscopy

3.0

234.2

1647

7594

UJF30

NOMESCO Finland

Ileoscopy through colon

3.4

176.8

754

2558

R53

ICD-10 Finland

Malaise and fatigue

2.4

146.1

1415

7302

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

140.8

1828

10665

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

104.1

794

3603

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

103.7

2318

16018

R11

ICD-10 Finland

Nausea and vomiting

2.8

98.5

553

2153

JN4AD

NOMESCO Finland

Body CT examination

2.5

89.6

680

3062

D64.9

ICD-10 Finland

Anaemia, unspecified

2.5

89.3

667

2981

N06AX11

ATC

mirtazapine; oral

1.9

84.0

1564

9928

A02BC02

ATC

pantoprazole; systemic

2.0

80.7

2951

23171

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

80.1

1110

6345

N03AX16

ATC

[U] pregabalin

2.0

78.6

1083

6173

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.4

74.1

282

873

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.1

73.0

876

4731

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

4.4

71.8

188

448

F50.0

ICD-10 Finland

Anorexia nervosa

11.0

71.3

R63.0

ICD-10 Finland

Anorexia

10.9

70.6

K30

ICD-10 Finland

Functional dyspepsia

2.3

70.0

580

2695

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

67.3

1224

7594

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

65.8

600

2900

R13

ICD-10 Finland

Dysphagia

2.6

64.4

413

1704

F50.9

ICD-10 Finland

Eating disorder, unspecified

7.5

63.6

123

A02BC05

ATC

esomeprazole; systemic

1.7

62.9

1714

11941

N05AH04

ATC

quetiapine; oral

2.0

62.6

796

4364

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

61.3

730

3906

AA1AD

NOMESCO Finland

CT of head and brain

1.8

60.2

1377

9097

K59.09

ICD-10 Finland

Constipation, unspecified

2.5

59.7

410

1746

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

58.5

899

5246

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

57.7

662

3487

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

56.4

503

2400

R42

ICD-10 Finland

Dizziness and giddiness

1.8

56.2

1086

6798

N06AX21

ATC

duloxetine; oral

2.2

55.6

549

2728

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

55.3

1278

8423

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

54.8

976

5953

A04

ICPC

Weakness/tiredness general

1.9

54.3

795

4552

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.7

54.1

312

1218

N03AX12

ATC

[U] gabapentin; oral

2.0

53.9

735

4109

F50.1

ICD-10 Finland

Atypical anorexia nervosa

10.3

52.0

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

51.9

417

1900

N05BA04

ATC

oxazepam; oral

1.7

51.0

1128

7310

N02AX02

ATC

tramadol; systemic, rectal

1.6

50.7

1786

13090

R51.80

ICD-10 Finland

Headache

2.0

50.6

693

3871

N06AX16

ATC

venlafaxine; oral

2.0

49.8

599

3198

R06.0

ICD-10 Finland

Dyspnoea

1.7

49.3

1239

8306

N05AH03

ATC

olanzapine; systemic

2.6

49.1

304

1229

H02AB06

ATC

prednisolone; systemic

1.6

48.4

1973

14938

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

4.6

48.3

117

262

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

47.9

913

5653

R03BB04

ATC

tiotropium bromide; inhalant

2.1

47.5

507

2588

UJD02

NOMESCO Finland

Gastroscopy

2.7

46.7

263

1014

R55

ICD-10 Finland

Syncope and collapse

2.0

46.6

555

2947

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

45.5

1475

10509

R4190

NOMESCO Finland

Nutritional therapy

2.9

45.5

227

821

K59.0

ICD-10 Finland

Constipation

2.5

45.3

313

1331

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

45.2

647

3657

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

44.2

589

3248

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.6

43.8

265

1058

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.4

43.6

322

1411

UJF92

NOMESCO Finland

Capsular endoscopy

3.8

43.4

137

374

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

42.5

480

2497

N03AX09

ATC

lamotrigine; oral

2.8

42.4

221

818

JN4BD

NOMESCO Finland

Extensive body CT

2.0

42.3

491

2578

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

42.2

1164

7932

N06AB04

ATC

citalopram; systemic

1.8

42.1

833

5192

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

41.9

502

2665

N03AG01

ATC

valproic acid; systemic, rectal

2.5

41.8

277

1155

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

41.4

1375

9803

N05BA01

ATC

diazepam; systemic, rectal

1.9

41.3

561

3110

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

40.7

765

4693

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

40.4

965

6323

A02BC03

ATC

lansoprazole; oral

1.6

39.9

1164

8024

N06AB06

ATC

sertraline; oral

2.0

39.2

484

2594

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.9

39.2

186

654

A06AD11

ATC

lactulose; oral

1.8

38.2

670

4020

A02BC01

ATC

omeprazole; systemic

1.6

37.9

1130

7816

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

37.7

458

2439

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

37.7

377

1871

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

37.3

1061

7250

M05BA04

ATC

alendronic acid; oral

2.0

37.0

426

2226

N03AE01

ATC

clonazepam; systemic

2.4

36.9

267

1158

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

36.5

433

2286

M54.5

ICD-10 Finland

Low back pain

1.6

36.4

1442

10630

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

36.3

797

5090

N05CF01

ATC

zopiclone; oral

1.6

36.0

1302

9397

R02

ICPC

Shortness of breath/dyspnoea

1.8

35.9

631

3781

SPAT1263

SPAT

Sampling

1.5

35.6

1686

12904

SPAT1301

SPAT

No procedures

1.6

35.4

1314

9532

K29.7

ICD-10 Finland

Gastritis, unspecified

2.7

34.8

187

703

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

6.2

34.7

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.9

34.3

167

595

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.7

34.3

195

754

N06AB10

ATC

escitalopram; oral

1.7

34.2

764

4893

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

33.8

721

4560

R03AC02

ATC

salbutamol; inhalant

1.5

33.6

2141

17339

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

33.5

370

1902

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

33.5

1177

8414

7832A

ICD-9 Finland

Symptoms concerning nutrition, metabolism and development, Abnormal loss of weight

+∞

33.4

N02BE01

ATC

paracetamol; systemic, rectal

1.8

33.4

3592

32677

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

33.3

389

2040

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

33.3

279

1289

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.3

33.3

271

1237

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.1

33.0

137

446

N06AX26

ATC

vortioxetine; oral

2.1

33.0

315

1533

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

32.9

375

1949

M79.6

ICD-10 Finland

Pain in limb

1.5

32.8

1738

13538

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.6

32.8

193

759

UKC02

NOMESCO Finland

Cystoscopy

1.7

32.8

715

4545

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

32.4

804

5283

R35

ICD-10 Finland

Polyuria

2.1

32.3

337

1697

G44.2

ICD-10 Finland

Tension-type headache

1.8

32.1

547

3242

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

32.1

413

2240

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

31.8

361

1873

C07AA05

ATC

propranolol; systemic

1.7

31.3

761

4969

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.6

31.0

160

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.1

30.6

305

1509

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.1

30.5

289

1402

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

29.9

430

2415

A01

ICPC

Pain general/multiple sites

1.8

29.9

457

2618

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

29.9

228

1012

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

29.8

472

2732

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

29.8

293

1442

S06.0

ICD-10 Finland

Concussion

1.8

29.7

460

2644

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

29.6

666

4257

SPAT1254

SPAT

Administration of medicine

1.7

29.4

664

4247

K86.8

ICD-10 Finland

Other specified diseases of pancreas

8.7

29.3

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

29.1

784

5244

R52.9

ICD-10 Finland

Pain, unspecified

1.8

29.0

445

2550

E87.6

ICD-10 Finland

Hypokalaemia

2.6

28.9

178

716

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

28.8

379

2069

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

28.7

397

2202

N05AX12

ATC

aripiprazole; systemic

2.7

28.4

159

610

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

28.2

553

3403

N06AB03

ATC

fluoxetine; oral

1.8

28.2

487

2892

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.2

28.2

241

1122

J01MA12

ATC

levofloxacin; systemic

1.6

28.1

751

5009

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.1

28.0

191

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

27.5

220

996

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

27.3

439

2550

TAB00

NOMESCO Finland

Lumbar puncture

2.4

27.2

193

830

P01AB01

ATC

metronidazole; oral, rectal

1.5

27.1

1464

11323

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

27.1

1008

7235

R52.2

ICD-10 Finland

Other chronic pain

2.5

26.8

175

724

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

26.7

249

1200

N06AA09

ATC

amitriptyline; systemic

1.8

26.7

395

2237

R07.3

ICD-10 Finland

Other chest pain

1.8

26.6

446

2623

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

26.5

272

1359

R19.4

ICD-10 Finland

Change in bowel habit

2.6

26.5

152

591

D11

ICPC

Diarrhoea

1.8

26.5

476

2857

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

26.4

1609

12711

R95

ICPC

Chron obstructive pulmonary disease

2.6

26.3

160

640

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

26.2

225

1049

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.1

26.2

109

356

L28

ICPC

Limited function/disability (L)

1.6

26.1

835

5794

N06AX12

ATC

bupropion; oral

2.1

26.1

250

1217

I95.1

ICD-10 Finland

Orthostatic hypotension

2.3

26.0

203

910

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.2

26.0

225

1053

C10AC01

ATC

colestyramine; oral

2.8

25.8

133

489

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

25.3

245

1197

PD5AD

NOMESCO Finland

CT of aorta

2.8

25.3

130

478

A06AC51

ATC

ispaghula, combinations; oral

2.2

25.2

207

948

N17

ICPC

Vertigo/dizziness

1.7

25.0

576

3693

P03

ICPC

Feeling depressed

1.8

24.9

376

2140

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

24.9

273

1397

J01FF01

ATC

clindamycin; systemic

1.5

24.9

1016

7415

L03

ICPC

Low back symptom/complaint

1.5

24.9

1135

8470

GD1AD

NOMESCO Finland

Thorax CT examination

2.0

24.8

288

1505

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.7

24.8

130

483

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

24.6

154

625

SPAT1260

SPAT

Consultation of another employee

1.6

24.6

706

4774

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

24.4

168

712

P20

ICPC

Memory disturbance

1.6

24.1

648

4311

XG410

NOMESCO Finland

Flow-volume spirometry

2.3

24.1

183

810

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.5

24.1

158

655

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

24.1

380

2192

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.2

24.0

218

1039

K29.4

ICD-10 Finland

Chronic atrophic gastritis

3.0

24.0

108

369

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

23.9

322

1769

N05AN01

ATC

lithium; oral

3.0

23.8

105

355

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

23.7

314

1714

ZY010

NOMESCO Finland

Hospital outpatient

2.2

23.6

212

1007

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.2

23.5

201

935

R50.9

ICD-10 Finland

Fever, unspecified

1.6

23.5

624

4138

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.4

23.4

162

689

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

23.4

260

1338

N05CD07

ATC

temazepam; oral

1.7

23.3

470

2909

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.5

23.0

148

608

J01DB01

ATC

cefalexin; oral

1.5

23.0

3218

29142

A02BA02

ATC

ranitidine; systemic

1.5

22.7

740

5140

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.0

22.5

251

1292

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.2

22.5

277

D09

ICPC

Nausea

2.1

22.5

210

1012

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

4.1

22.5

150

SPAT1310

SPAT

Counselling related to known health issue

1.4

22.4

1244

9593

OAB73, ,

SPAT

5.8

22.3

R00.2

ICD-10 Finland

Palpitations

1.9

22.2

311

1728

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.6

22.2

129

505

ZXD05

NOMESCO Finland

Urgent procedure

1.4

22.2

1111

8406

A28

ICPC

Limited function/disability NOS

1.5

22.1

790

5591

SPAT1240

SPAT

Therapeutic discussion

1.8

22.1

375

2209

A11

ICPC

Chest pain NOS

1.8

21.9

372

2193

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.6

21.9

129

509

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

21.8

315

1767

N05AX08

ATC

risperidone; systemic

1.8

21.6

355

2071

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

21.6

646

4398

XF404

NOMESCO Finland

Ambulatory ECG

1.8

21.5

366

2158

N02BF01

ATC

gabapentin; oral

1.7

21.5

409

2489

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

21.4

1448

11532

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.7

21.3

113

423

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.0

21.2

152

L04AX03

ATC

methotrexate; systemic

1.8

21.2

371

2205

JF2AD

NOMESCO Finland

Colon CT

5.4

21.2

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.1

21.0

205

1005

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.2

21.0

187

885

M25.5

ICD-10 Finland

Pain in joint

1.4

21.0

1203

9308

C07AB07

ATC

bisoprolol; oral

1.4

21.0

1941

16253

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

20.9

549

3626

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

20.9

647

4438

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.3

20.8

164

739

WX002

NOMESCO Finland

Sedation and analgesia

1.5

20.7

755

5361

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

20.7

335

1947

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

20.6

1601

13022

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

20.6

261

1404

N05AA02

ATC

levomepromazine; systemic

2.3

20.5

159

711

A02BC04

ATC

rabeprazole; oral

1.8

20.4

325

1878

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.1

20.4

268

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

20.3

699

4899

N05AH02

ATC

clozapine; systemic

3.4

20.3

223

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

20.2

134

559

D01

ICPC

Abdominal pain/cramps general

1.6

20.2

498

3237

WX892

NOMESCO Finland

Monitored bed care

1.8

20.2

319

1840

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

20.1

833

6062

J01MA02

ATC

ciprofloxacin; systemic

1.4

20.1

1476

11885

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

20.1

295

1664

L12

ICPC

Hand/finger symptom/complaint

1.5

20.1

675

4708

K86.1

ICD-10 Finland

Other chronic pancreatitis

4.1

20.1

132

SPAT1216

SPAT

Assessment of functional ability

1.5

20.0

642

4432

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.2

19.8

252

XW000

NOMESCO Finland

Bone marrow biopsy

2.1

19.8

184

886

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

19.8

176

833

D12

ICPC

Constipation

2.1

19.8

182

873

SPAT1053

SPAT

Memory test

1.5

19.7

606

4145

S18

ICPC

Laceration/cut

1.4

19.7

1864

15606

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

19.6

2665

23587

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

19.5

1000

7565

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

19.5

729

5194

A03

ICPC

Fever

1.5

19.4

630

4359

R64

ICD-10 Finland

Cachexia

14.6

19.4

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

19.3

717

5100

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

19.3

490

3208

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

19.2

277

1553

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.0

19.1

289

N04AA02

ATC

biperiden; systemic

3.1

19.1

258

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

19.0

239

1282

J02AC01

ATC

fluconazole; systemic

1.4

18.9

1304

10366

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.3

18.9

142

627

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

3.4

18.8

204

R33

ICD-10 Finland

Retention of urine

1.7

18.8

344

2070

M03BX02

ATC

tizanidine; oral

1.3

18.7

2167

18647

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

18.6

270

1516

P76

ICPC

Depressive disorder

1.9

18.6

238

1284

E0000UV, ,

ATC

1.4

18.5

1580

12978

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.0

18.5

199

1012

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

18.5

186

923

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.6

18.4

105

408

JN3AE, ,

SPAT

2.2

18.3

150

687

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.3

18.3

136

598

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

18.2

375

2327

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

18.2

2707

24137

N91.1

ICD-10 Finland

Secondary amenorrhoea

3.6

18.2

165

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

3.6

18.1

161

N06AX03

ATC

mianserin; oral

2.0

18.0

190

960

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

18.0

238

1299

N02AA05

ATC

oxycodone; systemic

1.5

18.0

744

5402

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

17.9

1565

12885

F61.0

ICD-10 Finland

Mixed personality disorders

3.4

17.9

191

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.6

17.7

159

K92.0

ICD-10 Finland

Haematemesis

2.5

17.6

107

429

A29

ICPC

General symptom/complaint other

1.5

17.6

544

3719

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

17.6

409

2618

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

17.6

1959

16700

D02

ICPC

Abdominal pain epigastric

1.8

17.6

249

1389

AXX01, ,

SPAT

2.0

17.5

190

969

SPAT1153

SPAT

Removal of sutures

1.4

17.5

1200

9510

H02AB09

ATC

hydrocortisone; systemic

2.5

17.4

111

455

K02.1

ICD-10 Finland

Caries of dentine

1.3

17.4

2123

18322

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

5.1

17.4

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.1

17.4

165

801

JN4CD

NOMESCO Finland

Very extensive body CT

2.2

17.4

155

735

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

17.2

248

1391

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

17.2

471

3135

R03BA05

ATC

fluticasone; inhalant

1.5

17.0

662

4745

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.2

17.0

218

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.5

17.0

103

413

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

16.9

1042

8104

R52.1

ICD-10 Finland

Chronic intractable pain

3.9

16.9

127

P01

ICPC

Feeling anxious/nervous/tense

1.6

16.8

421

2744

L17

ICPC

Foot/toe symptom/complaint

1.4

16.8

1181

9384

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

16.8

1447

11859

ZXE00

NOMESCO Finland

One hour or less

1.3

16.7

1401

11431

N02BF02

ATC

pregabalin; oral

1.8

16.7

257

1470

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

16.7

1566

12989

R05

ICD-10 Finland

Cough

1.4

16.7

821

6145

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

16.7

250

1419

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

16.6

462

3084

Z01.2

ICD-10 Finland

Dental examination

1.3

16.5

1680

14089

D06

ICPC

Abdominal pain localized other

1.7

16.5

346

2156

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

16.5

376

2394

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

5.6

16.5

SFA10

NOMESCO Finland

One-surface restoration

1.3

16.4

1992

17119

B82

ICPC

Anaemia other/unspecified

2.2

16.4

138

640

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.8

16.3

282

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

16.2

1147

9109

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

16.2

315

1924

J01CA04

ATC

amoxicillin; systemic

1.4

16.2

3124

28676

M79.1

ICD-10 Finland

Myalgia

1.5

16.1

533

3692

A03FA02

ATC

cisapride; oral, rectal

1.7

16.1

286

1704

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

16.1

280

1659

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

4.6

16.1

EBA00

NOMESCO Finland

Extraction of tooth

1.3

16.1

1355

11048

RD210, ,

NOMESCO Finland

2.7

16.0

330

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

16.0

884

6742

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

16.0

298

1799

W19

ICD-10 Finland

Unspecified fall

1.6

16.0

389

2515

N05AF03

ATC

chlorprothixene; systemic

2.6

16.0

371

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

16.0

1302

10559

N06AB05

ATC

paroxetine; oral

1.9

15.9

201

1080

L02

ICPC

Back symptom/complaint

1.6

15.9

373

2392

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.4

15.8

109

464

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.3

15.8

123

552

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

15.7

528

3668

N01

ICPC

Headache

1.6

15.7

426

2825

A04.8

ICD-10 Finland

Other specified bacterial intestinal infections

2.9

15.7

266

S70.0

ICD-10 Finland

Contusion of hip

2.0

15.7

168

853

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

15.7

565

3982

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

15.6

125

567

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

15.6

451

3033

A07AA02

ATC

nystatin; oral

1.8

15.6

232

1313

R04.2

ICD-10 Finland

Haemoptysis

2.1

15.6

147

713

N05BE01

ATC

buspirone; oral

2.4

15.5

110

474

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

15.5

138

654

N05AD01

ATC

haloperidol; systemic

2.3

15.5

122

550

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.7

15.3

321

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.4

15.3

410

ZYC01, ,

SPAT

1.6

15.2

411

2722

P01BA02

ATC

hydroxychloroquine; oral

1.7

15.2

295

1801

I73.0

ICD-10 Finland

Raynaud syndrome

2.9

15.2

238

N30.0

ICD-10 Finland

Acute cystitis

1.4

15.2

654

4769

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.1

15.2

151

747

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.5

15.1

394

WX004

NOMESCO Finland

Patient-controlled sedation

5.1

15.0

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.9

15.0

182

965

K92.1

ICD-10 Finland

Melaena

1.8

15.0

218

1225

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

15.0

255

1501

F50.8

ICD-10 Finland

Other eating disorders

6.3

15.0

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.3

15.0

115

513

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

15.0

273

1640

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

14.9

535

3769

E46

ICD-10 Finland

Unspecified protein-energy malnutrition

15.1

14.9

M54.3

ICD-10 Finland

Sciatica

1.8

14.8

217

1223

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

14.8

1612

13584

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.2

14.8

120

548

SPAT1211

SPAT

Application of soft bandage

1.6

14.8

347

2224

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

14.8

266

1592

M89.0

ICD-10 Finland

Algoneurodystrophy

4.0

14.8

103

R25.1

ICD-10 Finland

Tremor, unspecified

2.1

14.8

135

647

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

14.7

509

3555

M05BX04

ATC

denosumab; parenteral

1.7

14.7

264

1578

L01

ICPC

Neck symptom/complaint

1.5

14.7

587

4218

J01DA01

ATC

[U] cefalexin

1.3

14.7

2212

19450

K29.1

ICD-10 Finland

Other acute gastritis

3.1

14.7

200

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.5

14.7

375

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

14.6

472

3250

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

14.6

1095

8747

K86.2

ICD-10 Finland

Cyst of pancreas

3.2

14.6

180

J01AA02

ATC

doxycycline; systemic

1.3

14.6

2869

26140

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

14.6

246

1445

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.3

14.6

115

519

K29.8

ICD-10 Finland

Duodenitis

3.7

14.6

122

C03CA01

ATC

furosemide; systemic

1.3

14.6

1207

9786

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

14.5

258

1538

J37.0

ICD-10 Finland

Chronic laryngitis

2.1

14.5

130

618

E44.0

ICD-10 Finland

Moderate protein-energy malnutrition

10.9

14.5

J01FA06

ATC

roxithromycin; oral

1.3

14.5

1375

11365

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.5

14.4

378

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.5

14.4

366

J01EA01

ATC

trimethoprim; systemic

1.4

14.4

923

7197

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

14.4

842

6472

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

14.3

1886

16273

D10

ICPC

Vomiting

1.8

14.3

201

1118

N07BA03

ATC

varenicline; oral

2.0

14.3

152

770

N07BB01

ATC

disulfiram; oral

2.1

14.3

137

668

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

14.3

261

1568

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

14.2

716

5364

G20

ICD-10 Finland

Parkinson disease

2.1

14.2

137

670

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

14.2

197

1092

K29.6

ICD-10 Finland

Other gastritis

3.1

14.2

194

F93.89

ICD-10 Finland

Other childhood emotional disorders

3.9

14.0

107

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

14.0

198

1104

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

14.0

871

6756

SPAT1139

SPAT

Nutrition survey

2.1

14.0

138

681

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

14.0

286

1771

R96

ICPC

Asthma

1.6

14.0

381

2529

C01DA14

ATC

isosorbide mononitrate; oral

1.4

13.8

616

4515

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

3.3

13.8

151

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

13.7

158

824

N06AA10

ATC

nortriptyline; systemic

2.5

13.7

333

TGC00

NOMESCO Finland

Bronchial lavation

2.3

13.7

105

469

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

13.7

307

1947

J47

ICD-10 Finland

Bronchiectasis

2.5

13.6

346

G43.9

ICD-10 Finland

Migraine, unspecified

1.9

13.6

186

1026

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.8

13.6

231

L88

ICPC

Rheumatoid/seropositive arthritis

2.0

13.6

153

792

318

Kela drug reimbursment

Teriparatide

4.4

13.5

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.0

13.5

154

800

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

13.5

237

1408

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

13.4

350

2299

D93

ICPC

Irritable bowel syndrome

3.0

13.4

195

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

13.4

941

7430

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.2

13.4

115

538

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

13.4

120

571

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.9

13.4

206

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

13.4

263

1612

R60.0

ICD-10 Finland

Localized oedema

1.5

13.4

494

3495

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.7

13.3

273

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

13.3

155

811

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

13.3

430

2959

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.1

13.3

124

599

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.4

13.3

393

T03

ICPC

Loss of appetite

4.5

13.3

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

13.3

698

5263

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

13.3

335

2184

IHZ05, ,

SPAT

2.0

13.3

147

757

SPAT1097

SPAT

Recording of ECG

1.4

13.2

539

3886

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

13.2

263

1618

I95.9

ICD-10 Finland

Hypotension, unspecified

2.6

13.2

298

E000001, ,

ATC

1.4

13.2

681

5121

N05BA12

ATC

alprazolam; oral

1.6

13.2

337

2205

K03.66

ICD-10 Finland

Tooth plaque

1.6

13.1

298

1894

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

13.1

1586

13485

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

13.1

707

5353

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.7

13.1

232

1383

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

13.1

435

3013

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

13.0

434

R4110, ,

SPAT

1.5

13.0

509

3639

R06.4

ICD-10 Finland

Hyperventilation

2.9

13.0

204

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

13.0

782

6028

Z2446

NOMESCO Finland

Social worker

1.7

13.0

242

1463

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

13.0

310

1996

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.7

12.9

254

1556

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.1

12.9

120

579

L86

ICPC

Back syndrome with radiating pain

1.7

12.9

228

1357

R03BA08

ATC

ciclesonide; inhalant

1.6

12.9

300

1918

R10.0

ICD-10 Finland

Acute abdomen

2.1

12.9

122

593

IAA01, ,

SPAT

3.7

12.9

109

Z71.8

ICD-10 Finland

Other specified counselling

1.3

12.9

1232

10155

SPAT1262

SPAT

Handing over of treatment supplies

1.4

12.8

644

4818

Z00.0

ICD-10 Finland

General medical examination

1.4

12.8

721

5497

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

12.7

354

2359

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

12.7

2413

21662

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

12.7

156

833

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

12.6

894

7060

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.1

12.6

124

612

F32

ICD-10 Finland

Depressive episode

1.8

12.6

171

943

SPAT1234

SPAT

Support of social functional capacity

1.8

12.5

204

1187

P17

ICPC

Tobacco abuse

3.0

12.5

187

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

12.5

514

3709

K66.0

ICD-10 Finland

Peritoneal adhesions

5.2

12.5

EB1VA, ,

NOMESCO Finland

1.4

12.5

594

4401

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.8

12.5

177

989

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.4

12.4

131

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

4.2

12.4

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.3

12.4

141

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.5

12.4

313

WZC30

NOMESCO Finland

Teaching

1.4

12.4

613

4571

R06AE07

ATC

cetirizine; oral

1.3

12.4

1521

12932

L04

ICPC

Chest symptom/complaint

1.7

12.4

248

1528

A01AB09

ATC

miconazole; local oral

1.6

12.4

308

2002

JF1BD

NOMESCO Finland

Very extensive small bowel CT

4.4

12.4

R05

ICPC

Cough

1.3

12.3

922

7335

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

12.3

301

1947

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

3.9

12.3

XKD00

NOMESCO Finland

Uroflowmetry

1.4

12.3

596

4427

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

12.3

292

1876

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

12.3

172

957

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

12.3

216

1285

H02AB07

ATC

prednisone; oral

1.5

12.3

473

3371

E86

ICD-10 Finland

Volume depletion

2.1

12.3

108

511

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.9

12.2

SPAT1312

SPAT

General health counselling

1.3

12.2

1152

9466

WX402

NOMESCO Finland

General anaesthesia

1.4

12.2

785

6108

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.5

12.2

304

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

4.6

12.1

IGY02, ,

SPAT

2.8

12.1

207

A07EA06

ATC

budesonide; oral, local oral

2.0

12.1

132

677

K90.0

ICD-10 Finland

Coeliac disease

2.1

12.1

109

521

F32.1

ICD-10 Finland

Moderate depressive episode

1.8

12.1

186

1066

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

12.0

429

3011

S22.3

ICD-10 Finland

Fracture of rib

1.6

12.0

274

1744

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

12.0

155

841

N06AX22

ATC

agomelatine; oral

2.4

11.9

350

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

11.9

176

996

N03AF02

ATC

oxcarbazepine; oral

2.0

11.9

120

598

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

11.9

412

2876

183

Kela drug reimbursment

Lamotrigin and topiramate

3.6

11.9

106

R01AD09

ATC

mometasone; nasal

1.3

11.9

1522

12992

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

11.8

169

947

B37.0

ICD-10 Finland

Candidal stomatitis

3.0

11.7

162

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.4

11.7

310

UDC00

NOMESCO Finland

Ear microscopy

1.6

11.7

270

1724

H05AA02

ATC

teriparatide; parenteral

4.4

11.7

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

11.7

365

2495

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.8

11.7

159

878

J45.8

ICD-10 Finland

Mixed asthma

2.0

11.6

118

589

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

11.6

720

5564

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.7

11.6

240

D07AC01

ATC

betamethasone; topical

1.3

11.6

1291

10820

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

11.5

574

4281

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

11.5

330

2213

U07

ICPC

Urine symptom/complaint other

1.5

11.5

332

2230

P74

ICPC

Anxiety disorder/anxiety state

1.8

11.5

158

874

R07.2

ICD-10 Finland

Precordial pain

2.3

11.5

400

TAC99

NOMESCO Finland

Other blockade for chronic pain

3.8

11.4

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.3

11.4

388

N06AG02

ATC

moclobemide; oral

1.9

11.4

151

826

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

11.4

377

2607

L95

ICPC

Osteoporosis

1.8

11.4

164

921

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

4.0

11.4

R81

ICPC

Pneumonia

1.9

11.4

147

798

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.3

11.4

389

G04BD12

ATC

mirabegron; oral

1.4

11.4

469

3384

KED33

NOMESCO Finland

Transurethral incision of prostate

2.7

11.4

220

J01MA14

ATC

moxifloxacin; systemic

1.5

11.3

311

2066

L18

ICPC

Muscle pain

1.8

11.3

157

871

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

11.3

223

1368

T05

ICPC

Feeding problem of adult

3.0

11.3

160

M01AE02

ATC

naproxen; oral, rectal

1.3

11.3

1988

17575

WX725

NOMESCO Finland

Noninvasive ventilation

1.7

11.3

206

1238

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.2

11.3

442

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

11.3

780

6127

N04BC05

ATC

pramipexole; oral

1.6

11.2

278

1804

R03BA02

ATC

budesonide; inhalant

1.4

11.2

604

4563

R51

ICD-10 Finland

Headache

1.8

11.2

182

1059

PAW37

NOMESCO Finland

Biopsy of temporal artery

3.7

11.2

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.7

11.2

R54

ICD-10 Finland

Senility

4.6

11.2

SPAT1283

SPAT

Restricted health certificate

1.4

11.2

460

3318

R63.8

ICD-10 Finland

Other symptoms and signs concerning food and fluid intake

5.5

11.2

U02

ICPC

Urinary frequency/urgency

1.4

11.2

550

4095

M01AH02

ATC

rofecoxib; oral

1.4

11.1

440

3152

Z2445

NOMESCO Finland

Psychologist

1.9

11.1

135

719

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.8

11.1

170

974

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

11.0

387

2709

T91

ICPC

Vitamin/nutritional deficiency

3.1

11.0

147

H53.2

ICD-10 Finland

Diplopia

1.9

11.0

128

672

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.4

11.0

289

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

2.5

11.0

271

JAH01

NOMESCO Finland

Laparoscopy

1.9

11.0

143

779

Z08

ICPC

Social welfare problem

2.8

10.9

196

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

10.9

1630

14122

R03DC03

ATC

montelukast; oral

1.4

10.9

545

4064

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

4.5

10.9

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

4.5

10.9

J20

ICD-10 Finland

Acute bronchitis

1.5

10.9

351

2412

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

10.9

652

5006

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

2.7

10.9

202

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

2.1

10.9

101

488

AA400

NOMESCO Finland

Electroconvulsive therapy

3.6

10.9

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.6

10.9

L08

ICPC

Shoulder symptom/complaint

1.3

10.9

816

6481

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.2

10.9

384

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.9

10.9

134

717

N05CF02

ATC

zolpidem; oral

1.4

10.8

558

4183

Z72.0

ICD-10 Finland

Tobacco use

2.2

10.8

423

P99

ICPC

Psychological disorders other

2.1

10.8

102

496

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

10.8

1268

10675

G04CA02

ATC

tamsulosin; oral

1.3

10.8

874

7014

SFA30

NOMESCO Finland

Three-surface restoration

1.3

10.8

1418

12101

ZXA10

NOMESCO Finland

Bilateral

1.4

10.8

667

5148

R74

ICPC

Upper respiratory infection acute

1.3

10.8

1048

8618

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.7

10.8

178

1041

X58

ICD-10 Finland

Exposure to other specified factors

1.4

10.7

498

3668

H57.1

ICD-10 Finland

Ocular pain

1.9

10.7

136

734

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.1

10.7

105

518

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.8

10.7

187

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

10.7

191

1141

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.5

10.7

268

A27

ICPC

Fear of other disease NOS

1.7

10.7

195

1172

IHZ07, ,

SPAT

3.7

10.7

Z3231

NOMESCO Finland

Registered nurse

1.3

10.7

986

8055

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.9

10.6

166

S97

ICPC

Chronic ulcer skin

1.6

10.6

244

1556

L05

ICPC

Flank/axilla symptom/complaint

1.6

10.6

244

1557

N05AB03

ATC

perphenazine; systemic, rectal

2.0

10.6

116

596

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

10.6

290

1927

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.9

10.6

130

695

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.0

10.6

112

569

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

10.5

1016

8345

B81

ICPC

Anaemia vit B12/folate deficiency

1.8

10.5

149

834

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.9

10.4

120

627

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.2

10.4

410

M54

ICD-10 Finland

Dorsalgia

1.4

10.4

402

2863

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

1.9

10.4

132

713

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.2

10.4

372

A07EC01

ATC

sulfasalazine; oral, rectal

1.6

10.4

261

1701

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.0

10.4

147

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

10.4

120

629

K08.80

ICD-10 Finland

Toothache NOS

1.5

10.4

281

1863

107

Kela drug reimbursment

Pernicious anaemia

2.3

10.3

322

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

10.3

211

1308

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.0

10.3

115

595

M79.7

ICD-10 Finland

Fibromyalgia

2.0

10.3

106

533

K58

ICD-10 Finland

Irritable bowel syndrome

2.1

10.3

419

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

10.3

289

1931

SPAT1360

SPAT

Extensive global examination

1.6

10.3

248

1601

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.9

10.2

120

632

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.6

10.2

215

R12

ICD-10 Finland

Heartburn

1.5

10.2

285

1902

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.4

10.2

287

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

10.2

479

3536

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.2

10.2

408

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.2

10.2

408

ZX120

NOMESCO Finland

Intravenous

1.5

10.1

329

2266

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.7

10.1

164

955

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.0

10.1

101

503

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

10.1

361

2536

XF402

NOMESCO Finland

ECG with work load test

1.5

10.1

378

2679

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.0

10.1

490

J96.1

ICD-10 Finland

Chronic respiratory failure

2.1

10.0

410

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

10.0

328

2262

G43.3

ICD-10 Finland

Complicated migraine

2.6

10.0

217

N19

ICD-10 Finland

Unspecified kidney failure

1.8

10.0

147

831

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

10.0

673

5256

J05AB01

ATC

aciclovir; systemic

1.3

10.0

739

5853

WZC00, ,

SPAT

1.4

10.0

540

4080

SPAT1325

SPAT

Vaccination

1.3

10.0

1277

10843

WX704

NOMESCO Finland

Intubation

1.5

10.0

281

1879

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

9.9

955

7830

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.8

9.9

167

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

9.9

119

631

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.7

9.9

164

960

SPAT1252

SPAT

Overall medication plan or its review

1.6

9.9

245

1590

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.8

9.9

132

725

H03AA01

ATC

levothyroxine sodium; systemic

1.3

9.9

780

6231

L20

ICPC

Joint symptom/complaint NOS

1.8

9.9

134

740

Z3226

NOMESCO Finland

Physiotherapist

1.3

9.8

639

4964

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.3

9.8

323

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

9.8

154

888

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

9.8

343

2397

N06DA03

ATC

rivastigmine; oral, transdermal

1.7

9.8

176

1054

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

9.8

732

5804

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

9.8

321

2216

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.2

9.8

343

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

9.8

150

860

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

3.1

9.8

131

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

9.7

539

4086

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.3

9.7

312

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

9.7

298

2029

R07.0

ICD-10 Finland

Pain in throat

1.6

9.7

232

1495

D21

ICPC

Swallowing problem

2.3

9.7

300

K22.7

ICD-10 Finland

Barrett oesophagus

2.5

9.7

233

F06.7

ICD-10 Finland

Mild cognitive disorder

1.9

9.7

125

680

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

9.7

133

738

S72.0

ICD-10 Finland

Fracture of neck of femur

1.7

9.6

158

923

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

9.6

100

505

A02BDXX, ,

ATC

1.8

9.6

129

710

SPAT1229

SPAT

Assessment of need for aid

1.5

9.6

274

1837

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.4

9.6

252

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.9

9.6

126

689

ZXH06, ,

SPAT

1.7

9.6

180

1092

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.5

9.6

261

1733

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

9.5

135

756

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.6

9.5

250

1648

R39.1

ICD-10 Finland

Other difficulties with micturition

1.9

9.4

118

635

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.7

9.4

181

1104

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.9

9.4

116

621

C01CA24

ATC

epinephrine; parenteral

1.6

9.4

194

1205

N05AF05

ATC

zuclopenthixol; systemic

3.3

9.4

108

XG405

NOMESCO Finland

Education on PEF monitoring

2.5

9.4

236

KCV04

NOMESCO Finland

Distension of bladder with fluid

3.0

9.4

134

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

9.4

143

818

Y94.0

ICD-10 Finland

Accident at home

2.2

9.4

336

JF2BD

NOMESCO Finland

Extensive colon CT

3.0

9.4

129

N03AF01

ATC

carbamazepine; oral, rectal

1.7

9.3

167

1000

SPAT1172

SPAT

Guidance concerning hydration

2.1

9.3

429

K07.60

ICD-10 Finland

Snapping jaw

1.7

9.3

158

932

A02BA04

ATC

nizatidine; systemic

1.5

9.3

255

1694

OAB50, ,

SPAT

1.5

9.3

290

1981

R03AC13

ATC

formoterol; inhalant

1.7

9.3

168

1009

R01AD08

ATC

fluticasone; nasal

1.3

9.3

908

7453

R4120

NOMESCO Finland

Occupational therapy

1.6

9.3

228

1479

A99

ICPC

Disease/condition unspecnature/site

1.4

9.3

383

2763

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

9.2

239

1568

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

9.2

447

3314

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.9

9.2

111

590

M54.8

ICD-10 Finland

Other dorsalgia

1.7

9.2

154

905

XG466

NOMESCO Finland

Sleep oxymetry

1.9

9.2

105

548

D82

ICPC

Teeth/gum disease

1.2

9.2

1237

10541

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

3.5

9.2

N06AX05

ATC

trazodone; oral

2.1

9.2

392

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

2.9

9.2

147

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.8

9.1

125

694

H03BB01

ATC

carbimazole; oral

1.8

9.1

134

760

N03AX11

ATC

topiramate; oral

2.2

9.1

354

J01FA09

ATC

clarithromycin; systemic

1.3

9.1

1004

8365

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.7

9.0

167

1009

J01FA10

ATC

azithromycin; systemic

1.2

9.0

1942

17380

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.8

9.0

125

695

Z2221

NOMESCO Finland

Medical doctor

1.3

9.0

918

7568

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.3

9.0

101

EC1VA, ,

NOMESCO Finland

1.7

9.0

159

949

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

9.0

528

4037

M48.0

ICD-10 Finland

Spinal stenosis

1.4

9.0

454

3389

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.1

9.0

415

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

9.0

303

2103

R1250

NOMESCO Finland

Evaluation of functional capability

2.0

9.0

470

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.8

8.9

120

661

N05BA09

ATC

clobazam; oral

3.8

8.9

SPAT1307

SPAT

Psychosocial counselling and guidance

1.6

8.9

186

1159

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

8.9

714

5706

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.3

8.9

292

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

3.1

8.9

117

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

3.5

8.9

IHZ04, ,

SPAT

2.5

8.9

225

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

4.3

8.9

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

4.3

8.9

M01AB05

ATC

diclofenac; systemic, rectal

1.2

8.9

2276

20723

K92.9

ICD-10 Finland

Disease of digestive system, unspecified

3.6

8.8

R63.1

ICD-10 Finland

Polydipsia

6.8

8.8

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.0

8.8

487

B01AC04

ATC

clopidogrel; oral

1.3

8.8

611

4789

M54.2

ICD-10 Finland

Cervicalgia

1.5

8.8

263

1782

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.7

8.8

156

933

F45.0

ICD-10 Finland

Somatization disorder

4.0

8.8

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

8.8

321

2264

M54.1

ICD-10 Finland

Radiculopathy

1.8

8.8

133

761

GX1K5

NOMESCO Finland

Diffusion capacity

3.4

8.7

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

1.8

8.7

116

637

OAB43, ,

SPAT

0.7

8.7

458

6000

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

8.7

1340

11570

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

8.7

384

2803

N87

ICPC

Parkinsonism

2.2

8.7

302

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.8

8.6

117

647

Z00.8

ICD-10 Finland

Other general examinations

1.5

8.6

271

1855

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

8.6

233

1545

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

8.6

361

2611

J45

ICD-10 Finland

Asthma

1.4

8.6

338

2416

C08CA05

ATC

nifedipine; systemic

1.6

8.6

203

1305

R32

ICD-10 Finland

Unspecified urinary incontinence

1.9

8.6

108

583

H81.3

ICD-10 Finland

Other peripheral vertigo

1.9

8.6

101

534

H02AB04

ATC

methylprednisolone; systemic

1.4

8.5

466

3522

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.2

8.5

311

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.9

8.5

494

SPE01

NOMESCO Finland

Mucosa-supported partial denture

2.1

8.5

398

R07.1

ICD-10 Finland

Chest pain on breathing

2.3

8.4

255

S01.0

ICD-10 Finland

Open wound of scalp

1.5

8.4

279

1931

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

8.4

164

1006

H92.0

ICD-10 Finland

Otalgia

1.6

8.4

212

1385

I20.09

ICD-10 Finland

Unstable angina

1.6

8.4

204

1322

78840

ICD-8 Finland

Other general symptoms, Loss of weight

+∞

8.3

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.2

8.3

301

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.7

8.3

154

932

U08

ICPC

Urinary retention

2.0

8.3

421

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

8.3

299

2103

R30.0

ICD-10 Finland

Dysuria

1.7

8.3

150

902

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

8.2

149

896

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.8

8.2

115

642

P29

ICPC

Psychological sympt/compl other

1.5

8.2

231

1544

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.6

8.2

170

1058

Z53.8

ICD-10 Finland

Procedure not carried out for other reasons

3.8

8.2

R21

ICPC

Throat symptom/complaint

1.3

8.2

672

5383

R03AC03

ATC

terbutaline; inhalant

1.4

8.2

431

3237

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.2

8.2

290

FN1AD

NOMESCO Finland

CT of coronary arteries

2.2

8.2

290

WVA20, ,

SPAT

1.7

8.2

135

791

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.6

8.2

166

1028

-50

ICPC

Medication/prescr/renewal

1.7

8.2

142

844

R68.2

ICD-10 Finland

Dry mouth, unspecified

3.2

8.2

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.5

8.2

266

1833

R19.5

ICD-10 Finland

Other faecal abnormalities

2.2

8.2

323

R31

ICD-10 Finland

Unspecified haematuria

1.4

8.2

370

2712

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.4

8.2

228

E83.50

ICD-10 Finland

Hypercalcemia

2.4

8.1

222

R06.2

ICD-10 Finland

Wheezing

1.7

8.1

159

976

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

8.1

827

6808

G62.8

ICD-10 Finland

Other specified polyneuropathies

2.8

8.1

146

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.8

8.1

146

N03AX14

ATC

levetiracetam; systemic

1.9

8.1

530

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.8

8.1

135

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

3.1

8.1

103

Z01.7

ICD-10 Finland

Laboratory examination

1.3

8.1

572

4493

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.7

8.1

144

863

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.8

8.1

120

683

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.7

8.1

153

932

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

3.2

8.1

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.4

8.1

444

3360

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

2.8

8.1

141

L04AA13

ATC

[U] leflunomide

2.0

8.0

399

A02BX02

ATC

sucralfate; oral

1.7

8.0

132

774

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

8.0

557

4364

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.0

8.0

109

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.8

8.0

105

576

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

2.5

8.0

188

SPAT1281

SPAT

Other administrative function

1.5

8.0

266

1844

S20.2

ICD-10 Finland

Contusion of thorax

1.6

7.9

180

1147

N02AC04

ATC

dextropropoxyphene; oral

1.8

7.9

123

709

N06AA06

ATC

trimipramine; systemic

2.0

7.9

415

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

2.6

7.9

171

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.7

7.9

142

853

SPE90

NOMESCO Finland

Other partial denture

2.0

7.9

388

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.1

7.9

361

N02CX04, ,

ATC

2.2

7.9

308

H01

ICPC

Ear pain/earache

1.4

7.9

396

2954

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.5

7.9

208

1373

L76

ICPC

Fracture: other

1.8

7.9

116

659

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.7

7.8

124

719

L50.9

ICD-10 Finland

Urticaria, unspecified

1.8

7.8

121

697

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

3.1

7.8

100

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

2.4

7.8

208

J43.9

ICD-10 Finland

Emphysema, unspecified

2.2

7.8

290

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.2

7.8

290

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

7.8

528

4121

WX320

NOMESCO Finland

Spinalanesthesy

1.3

7.8

863

7176

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

3.0

7.8

111

WVA20

NOMESCO Finland

Medicine administration

1.9

7.7

531

R03BA01

ATC

beclometasone; inhalant

1.4

7.7

446

3399

SFA20

NOMESCO Finland

Two-surface restoration

1.2

7.7

1966

17780

N06AA04

ATC

clomipramine; systemic

2.3

7.7

259

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

3.7

7.7

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.7

7.7

129

760

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

2.0

7.7

378

F32.8

ICD-10 Finland

Other depressive episodes

2.3

7.7

253

J01CA08

ATC

pivmecillinam; oral

1.2

7.7

1317

11466

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.1

7.7

101

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

3.5

7.7

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

4.3

7.7

N05AA01

ATC

chlorpromazine; systemic, rectal

2.6

7.7

168

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.6

7.7

154

953

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

7.7

147

899

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.5

7.7

218

1463

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.4

7.6

204

A05

ICPC

Feeling ill

1.5

7.6

216

1447

ECB00

NOMESCO Finland

Suture of gingiva

1.7

7.6

125

732

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

7.6

331

2408

D07AD01

ATC

clobetasol; topical

1.3

7.6

544

4275

H02AA02

ATC

fludrocortisone; oral

2.8

7.6

129

Z54.0

ICD-10 Finland

Convalescence following surgery

2.3

7.6

236

M77.1

ICD-10 Finland

Lateral epicondylitis

1.5

7.6

204

1353

R5599

NOMESCO Finland

Other rehabilitation service

1.8

7.5

543

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.7

7.5

123

720

UJF02

NOMESCO Finland

Peroral enteroscopy

3.4

7.5

K11.70

ICD-10 Finland

Hypoptyalism

3.2

7.5

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

1.8

7.5

544

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

7.5

678

5498

UJK02

NOMESCO Finland

ERCP

1.9

7.5

516

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.5

7.5

238

1635

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.1

7.5

322

N04BD01

ATC

selegiline; oral

2.3

7.5

244

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.0

7.4

383

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.2

7.4

257

L75

ICPC

Fracture: femur

2.3

7.4

238

XA800

NOMESCO Finland

Neuropsychological investigation

1.7

7.4

138

837

R41.0

ICD-10 Finland

Disorientation, unspecified

1.8

7.4

112

641

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.1

7.4

316

U01

ICPC

Dysuria/painful urination

1.4

7.4

273

1929

Z04.3

ICD-10 Finland

Examination and observation following other accident

2.1

7.4

323

M80

ICD-10 Finland

Osteoporosis with pathological fracture

2.7

7.4

142

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

1.8

7.4

525

A07AA09

ATC

vancomycin; oral

2.3

7.4

245

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

3.3

7.4

K22.1

ICD-10 Finland

Ulcer of oesophagus

2.1

7.3

305

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

1.9

7.3

428

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

2.0

7.3

366

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

4.1

7.3

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

2.8

7.3

121

U05

ICPC

Urination problems other

1.5

7.2

198

1318

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.1

7.2

326

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

7.2

852

7125

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.1

7.2

293

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.4

7.2

344

2544

F01

ICPC

Eye pain

1.8

7.2

551

N17.8

ICD-10 Finland

Other acute renal failure

2.3

7.2

210

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

7.2

325

2382

K63.5

ICD-10 Finland

Polyp of colon

2.0

7.2

402

P06

ICPC

Sleep disturbance

1.4

7.2

404

3068

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

7.2

323

2366

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.5

7.2

192

1272

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.5

7.2

223

1525

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

3.9

7.2

L29

ICPC

Musculoskeletal sympt/complt other

1.4

7.1

309

2249

R5110, ,

SPAT

1.4

7.1

312

2275

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

2.0

7.1

335

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

2.9

7.1

106

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

3.4

7.1

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

2.1

7.1

295

F31

ICD-10 Finland

Bipolar affective disorder

2.6

7.1

151

E23.03

ICD-10 Finland

Lack of ACTH

6.6

7.1

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

2.2

7.1

243

F84.5

ICD-10 Finland

Asperger syndrome

3.3

7.1

F05.9

ICD-10 Finland

Delirium, unspecified

1.9

7.1

425

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.2

7.1

269

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.4

7.1

337

2492

S29

ICPC

Skin symptom/complaint other

1.3

7.1

727

5984

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.3

7.1

237

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.6

7.1

160

1021

G24.3

ICD-10 Finland

Spasmodic torticollis

2.7

7.0

140

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.0

7.0

398

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.5

7.0

218

1490

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

2.7

7.0

129

L04AA06

ATC

mycophenolic acid; systemic

2.1

7.0

310

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.5

7.0

211

1434

R30.1

ICD-10 Finland

Vesical tenesmus

1.9

7.0

399

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

7.0

174

1135

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

7.0

648

5270

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

6.9

209

1420

N06AA12

ATC

doxepin; systemic

1.6

6.9

165

1065

K07

ICPC

Swollen ankles/oedema

1.5

6.9

180

1185

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.5

6.9

234

1627

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.6

6.9

150

947

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.0

6.9

380

GAB10

NOMESCO Finland

Antero- or postero-lateral thoracotomy

3.7

6.9

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

3.7

6.9

K55.1

ICD-10 Finland

Chronic vascular disorders of intestine

5.4

6.9

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

6.9

1038

8904

SPAT1238

SPAT

Brief therapy

2.3

6.9

208

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.0

6.9

346

L16

ICPC

Ankle symptom/complaint

1.3

6.9

405

3096

K04.0

ICD-10 Finland

Pulpitis

1.5

6.9

244

1713

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.6

6.9

162

1044

N03AX18

ATC

lacosamide; systemic

3.1

6.9

SPAT1043

SPAT

Audiometry

1.4

6.8

367

2766

XQ800

NOMESCO Finland

Prick test

1.5

6.8

212

1449

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

6.8

219

1507

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.2

6.8

247

D07AA02

ATC

hydrocortisone; topical

1.3

6.8

443

3435

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

6.8

161

1037

XCK00

NOMESCO Finland

Perimetry

1.5

6.8

203

1376

S20

ICPC

Corn/callosity

1.9

6.8

424

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

1.9

6.8

417

M05BA07

ATC

risedronic acid; oral

1.8

6.8

103

591

G04CB01

ATC

finasteride; oral

1.3

6.8

385

2926

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.1

6.8

307

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

2.6

6.8

137

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.6

6.8

160

1031

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.5

6.8

172

1127

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

6.8

350

2623

S50.0

ICD-10 Finland

Contusion of elbow

1.8

6.8

555

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

2.1

6.8

281

C08DA01

ATC

verapamil; systemic

1.6

6.8

142

890

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.4

6.7

173

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.8

6.7

115

KH1AD

NOMESCO Finland

CT of urinary organs

1.7

6.7

114

676

G44.8

ICD-10 Finland

Other specified headache syndromes

2.3

6.7

217

TJD20

NOMESCO Finland

Change of gastrostomy tube

3.5

6.7

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

3.5

6.7

H25.8

ICD-10 Finland

Other senile cataract

1.3

6.7

413

3179

S72.1

ICD-10 Finland

Pertrochanteric fracture

1.9

6.7

455

K08.3

ICD-10 Finland

Retained dental root

1.4

6.7

257

1831

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.0

6.7

336

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

3.2

6.7

K62.3

ICD-10 Finland

Rectal prolapse

2.3

6.7

211

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

2.1

6.7

289

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.5

6.7

150

R51.81

ICD-10 Finland

Facial pain NOS

1.9

6.7

399

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

6.7

224

1557

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.1

6.7

263

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

2.2

6.7

237

JF1AD

NOMESCO Finland

Small bowel CT

2.8

6.6

116

A07.8

ICD-10 Finland

Other specified protozoal intestinal diseases

6.4

6.6

P73

ICPC

Affective psychosis

4.0

6.6

L11

ICPC

Wrist symptom/complaint

1.4

6.6

302

2219

E05.80

ICD-10 Finland

Subacute thyrotoxicosis

2.7

6.6

122

R06.5

ICD-10 Finland

Mouth breathing

1.4

6.6

275

1989

F34.1

ICD-10 Finland

Dysthymia

1.7

6.6

105

612

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

3.6

6.6

M01AH01

ATC

celecoxib; oral

1.3

6.6

574

4631

XG474

NOMESCO Finland

Exhalation nntrogen oxide

1.9

6.6

437

SPAT1167

SPAT

Insertion of urinary catheter

1.7

6.6

111

658

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.7

6.5

107

628

I95.8

ICD-10 Finland

Other hypotension

3.3

6.5

UDM02

NOMESCO Finland

Sinoscopy

2.0

6.5

353

K85

ICD-10 Finland

Acute pancreatitis

2.2

6.5

252

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

1.8

6.5

510

N32.0

ICD-10 Finland

Bladder-neck obstruction

2.8

6.5

106

S50.1

ICD-10 Finland

Contusion of other and unspecified parts of forearm

2.4

6.5

170

H25.0

ICD-10 Finland

Senile incipient cataract

1.4

6.5

235

1656

M81.8

ICD-10 Finland

Other osteoporosis

2.5

6.5

164

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

6.5

465

3655

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

6.5

201

1374

R09.1

ICD-10 Finland

Pleurisy

2.1

6.5

299

R03BB07

ATC

umeclidinium bromide; inhalant

2.7

6.5

123

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

2.7

6.5

123

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.7

6.5

121

736

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.0

6.5

347

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.3

6.5

195

-31

ICPC

Medical examin/health eval partial

1.5

6.5

226

1582

R4110

NOMESCO Finland

Physiotherapy

1.2

6.5

956

8177

SPAT1243

SPAT

Psychiatric/psychological examination

1.9

6.5

396

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.3

6.5

189

AA1XD

NOMESCO Finland

Other special CT of head and brain

3.6

6.5

SBB10

NOMESCO Finland

Dental impressions

1.4

6.5

232

1633

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.5

6.5

178

1188

K90.9

ICD-10 Finland

Intestinal malabsorption, unspecified

5.3

6.4

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

6.4

256

1837

S01XA18

ATC

ciclosporin; ophthalmic

2.8

6.4

107

F98.2

ICD-10 Finland

Feeding disorder of infancy and childhood

7.4

6.4

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.6

6.4

138

871

Y94.8

ICD-10 Finland

Other leisure activity accident

1.8

6.4

528

G25.0

ICD-10 Finland

Essential tremor

1.8

6.4

528

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

6.4

250

1788

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.1

6.4

261

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

6.4

1359

12033

N06AX17

ATC

milnacipran; oral

2.6

6.4

136

N05AE04

ATC

ziprasidone; systemic

3.7

6.4

A06AX04

ATC

linaclotide; oral

3.7

6.4

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

3.7

6.4

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

6.3

196

1340

M01AB55

ATC

diclofenac, combinations; oral

1.5

6.3

218

1522

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.2

6.3

229

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

3.0

6.3

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

6.3

162

1064

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.5

6.3

171

1137

SPAT1104

SPAT

Monitoring of emergency patient

1.5

6.3

211

1465

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.6

6.3

140

890

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

5.2

6.3

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.3

6.3

365

2784

K02

ICD-10 Finland

Dental caries

1.5

6.3

204

1408

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

1.8

6.3

443

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

5.5

6.3

C03DA01

ATC

spironolactone; oral

1.3

6.3

434

3395

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

6.3

280

2049

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

3.3

6.3

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

3.3

6.3

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

6.3

1173

10261

WW200

NOMESCO Finland

Immunization

1.8

6.3

480

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

6.3

188

1278

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.0

6.3

324

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.0

6.3

331

R28

ICPC

Limited function/disability (R)

2.1

6.2

250

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.0

6.2

338

J01DA09

ATC

[U] cefadroxil

1.2

6.2

815

6882

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.9

6.2

416

M05BX03

ATC

strontium ranelate; oral

3.0

6.2

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

6.2

211

1470

M35.7

ICD-10 Finland

Hypermobility syndrome

2.4

6.2

174

R52.0

ICD-10 Finland

Acute pain

1.7

6.2

105

623

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

2.2

6.2

225

N93.9

ICD-10 Finland

Abnormal uterine and vaginal bleeding, unspecified

2.0

6.2

305

3AC01, ,

NOMESCO Finland

2.5

6.2

150

A03CA02

ATC

clidinium and psycholeptics; oral

1.5

6.2

181

1225

N02AA03

ATC

hydromorphone; systemic, rectal

4.0

6.2

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

3.1

6.2

ZY000

NOMESCO Finland

Hospital inpatient

2.3

6.1

181

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.8

6.1

542

SPAT1255

SPAT

Intravenous administration of medicine

1.4

6.1

220

1549

R4140

NOMESCO Finland

Psychotherapy

3.3

6.1

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

3.3

6.1

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.2

6.1

226

NDA30

NOMESCO Finland

Exploration of joint of wrist or hand, arthroscopic

2.8

6.1

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.7

6.1

111

672

M22.4

ICD-10 Finland

Chondromalacia patellae

1.9

6.1

412

W0A10

NOMESCO Finland

Mapping of psychosocial situation

4.1

6.1

SFE01

NOMESCO Finland

Carriage renovation

4.1

6.1

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.5

6.1

156

1026

EBA30

NOMESCO Finland

Extraction of root of tooth

1.5

6.1

193

1328

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

3.0

6.1

G50.1

ICD-10 Finland

Atypical facial pain

2.1

6.1

280

N76.0

ICD-10 Finland

Acute vaginitis

1.5

6.0

164

1092

WX730

NOMESCO Finland

Conventional respirator

2.1

6.0

247

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.7

6.0

575

R03DA04

ATC

theophylline; systemic, rectal

1.5

6.0

166

1109

ZXD00

NOMESCO Finland

Emergency procedure

1.7

6.0

553

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000570) Elastase.pancreatic [Mass/mass] in Stool

626

1181

6.08

307.65

1.5

1.4

294.37

272.21

ug/g

1.32

364

695

(40768797) Stomach Pathology biopsy report

1454

5117

3.85

307.65

1.4

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1088

3585

3.77

277.14

2.1

2.2

408.43

377.03

nmol/l

4.97

1016

3310

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2228

11825

2.94

246.83

3.1

2.7

59.62

67.45

u/l

0.59

2049

10928

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1789

8455

2.98

245.57

1.5

1.3

1.61

1.71

u/ml

0.13

454

2146

(3024561) Albumin [Mass/volume] in Serum or Plasma

2838

17353

3.07

238.34

5.5

5.3

35.56

35.33

g/l

1.32

2674

16256

(3006315) Basophils [#/volume] in Blood

2972

19122

3.02

217.98

7.7

6.4

0.04

e9/l

0.26

2635

16259

(3007164) IgA [Mass/volume] in Serum or Plasma

1593

7449

2.86

217.42

1.6

1.5

2.41

2.46

g/l

0.35

934

4435

(3013115) Eosinophils [#/volume] in Blood

3027

19692

3.06

217.10

8.0

6.7

0.18

0.19

e9/l

6.37

2725

17028

(3001604) Monocytes [#/volume] in Blood

2962

19068

3.00

216.13

7.7

6.4

0.58

0.60

e9/l

5.21

2633

16203

(3019198) Lymphocytes [#/volume] in Blood

2981

19489

2.95

206.72

7.8

6.5

1.81

1.91

e9/l

2.19

2708

16981

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3008

19767

2.96

206.43

9.0

7.7

1.22

1.21

mmol/l

5.41

2576

17079

(3022096) Basophils/Leukocytes in Blood

2789

17642

2.82

205.60

8.0

6.8

0.69

0.67

1.34

2626

16500

(3006504) Eosinophils/Leukocytes in Blood

2790

17655

2.82

205.45

7.9

6.7

2.66

2.84

3.99

2631

16522

(3019069) Monocytes/Leukocytes in Blood

2793

17689

2.82

205.23

8.0

6.8

8.75

8.97

3.91

2633

16550

(3048689) Calprotectin [Mass/mass] in Stool

1141

4666

3.00

196.49

2.1

2.4

132.80

141.39

ug/g

0.33

875

3712

(3002030) Lymphocytes/Leukocytes in Blood

2792

18037

2.72

190.73

8.0

6.7

26.94

27.39

1.34

2663

17067

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2967

19767

2.82

190.43

6.9

6.7

11.57

12.04

umol/l

0.93

2860

18826

(3018010) Neutrophils/Leukocytes in Blood

2743

17694

2.67

185.68

7.8

6.6

57.99

57.46

1.45

2628

16868

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2744

17749

2.65

183.89

8.2

7.0

1.22

1.21

mmol/l

8.15

2553

16371

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1918

10711

2.49

172.68

2.7

2.4

2.63

2.83

mg/l

3.58

1648

9244

(3013650) Neutrophils [#/volume] in Blood by Automated count

3060

21405

2.70

165.55

10.6

9.7

4.13

4.17

e9/l

0.39

2741

18459

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1088

4779

2.74

159.63

3.4

4.3

228.61

249.16

u/l

4.14

1027

4513

(3020630) Protein [Mass/volume] in Serum or Plasma

880

3497

2.93

155.73

2.1

2.7

66.40

66.15

g/l

0.41

806

3208

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1313

6440

2.53

152.68

2.7

2.24

2.30

g/l

3.06

1207

5955

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3509

26784

3.16

152.25

6.6

4.5

12.83

mm/h

0.00

3326

24957

(3021960) Folate [Moles/volume] in Serum or Plasma

1951

11573

2.31

145.84

2.1

1.7

20.01

20.26

nmol/l

0.25

1656

9749

(3022948) Iron [Moles/volume] in Serum or Plasma

1350

6868

2.44

143.42

2.7

12.88

12.63

umol/l

0.57

1248

6407

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2584

17358

2.32

141.87

3.8

3.2

137.27

127.76

ug/l

1.44

2381

16108

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1220

5954

2.49

141.70

2.7

2.8

23.17

22.11

1.42

1129

5542

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2557

17216

2.29

137.90

2.7

2.2

93.44

94.94

pmol/l

0.90

1537

9077

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3560

28038

3.06

132.86

10.6

8.4

81.30

80.92

u/l

0.14

3434

26578

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

464

1418

3.56

126.05

2.4

3.5

44.04

64.14

mg/l

0.75

401

1208

(3034860) Kappa light chains.free [Mass/volume] in Serum

462

1420

3.54

124.35

2.4

3.4

40.14

92.94

mg/l

0.78

395

1209

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2485

17001

2.17

122.27

3.0

2.5

77.79

77.75

nmol/l

0.02

2229

15259

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

870

3875

2.58

120.28

2.4

2.3

0.21

g/l

0.20

793

3616

(3019309) Folate [Moles/volume] in Red Blood Cells

1284

6846

2.28

118.34

2.0

1.8

1106.39

1162.71

nmol/l

1.25

981

5143

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1088

5469

2.35

114.70

5.9

6.3

1.05

mmol/l

0.05

1005

5101

(3027945) Reticulocytes/Erythrocytes in Blood

1012

4929

2.40

114.67

2.4

2.7

1.64

1.79

5.23

894

4386

(36660697) Celiac disease serology panel - Serum

724

3017

2.70

114.05

1.3

1.2

—

(3018418) pH of Serum or Plasma

1891

11876

2.10

113.66

4.9

4.3

7.39

7.40

1.35

1397

8573

(3037522) Nuclear Ab [Titer] in Serum

1008

4937

2.38

112.51

1.5

1.3

590.00

506.94

titre

0.62

236

1069

(3023520) Reticulocytes [#/volume] in Blood

833

3839

2.47

105.77

2.4

2.6

62.34

69.03

e9/l

7.79

623

2774

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

406

1271

3.44

105.64

2.3

3.3

3.90

3.02

ratio

0.14

225

732

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3426

27441

2.52

105.14

5.5

4.4

15.06

14.88

pmol/l

3.90

3153

24980

(46235355) HIV 1 and 2 tests - Meaningful Use set

1151

6115

2.23

104.94

1.8

1.9

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

487

1718

3.08

103.95

2.0

2.4

7.21

7.43

g/l

2.03

448

1565

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

466

1607

3.14

103.41

1.9

2.4

2.81

2.93

g/l

1.89

426

1455

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

484

1716

3.06

102.35

2.0

2.4

3.52

3.74

g/l

2.65

446

1564

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

484

1718

3.06

102.13

2.0

2.4

4.12

4.20

g/l

1.20

447

1566

(3022145) Colonoscopy Study observation

880

4220

2.38

101.90

1.3

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2029

13436

2.01

101.71

3.1

3.5

2.35

2.36

mmol/l

2.39

1823

12142

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1858

11980

2.01

99.92

2.7

2.2

177.77

212.58

u/l

0.97

1766

11319

(3005719) IgG [Mass/volume] in Serum or Plasma

677

2901

2.60

99.83

2.7

2.9

10.41

10.51

g/l

0.24

632

2671

(3032080) INR in Blood by Coagulation assay

2489

17924

1.99

95.65

16.9

16.7

1.25

1.29

inr

3.59

2121

15045

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2962

22799

2.08

92.84

4.4

3.4

48.22

50.19

u/l

0.55

2789

21209

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

424

1496

3.05

90.00

2.0

2.4

0.35

0.94

g/l

4.59

364

1277

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1176

6690

2.06

87.18

3.9

3.5

0.81

0.82

mmol/l

1.06

1101

6280

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

412

1488

2.97

83.70

2.0

2.4

10.08

10.26

g/l

0.39

366

1323

(3028026) IgM [Mass/volume] in Serum or Plasma

547

2294

2.60

83.39

1.8

1.9

1.14

1.35

g/l

2.43

510

2096

(3013826) Glucose [Moles/volume] in Serum or Plasma

2879

22435

1.95

80.31

6.8

5.3

6.54

6.74

mmol/l

6.74

2777

21295

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

363

1263

3.06

78.64

2.1

2.3

0.01

0.02

g/l

0.29

327

1133

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2039

14378

1.83

76.44

5.1

4.1

34.96

91.76

ng/l

1.16

1554

10552

(3031040) Bacteria [#/volume] in Urine by Automated count

3067

24639

1.97

75.26

6.5

5.1

2162.50

1434.24

e6/l

0.14

353

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

342

1217

2.98

71.02

2.0

2.3

0.00

g/l

0.50

302

1068

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3712

32389

2.56

68.93

7.2

5.5

1.87

1.96

mu/l

3.46

3479

29797

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

322

1133

3.00

68.16

2.1

2.4

0.00

g/l

-0.00

302

1067

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1748

12072

1.78

67.49

3.7

3.3

37.03

36.78

u/l

0.02

1650

11385

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

767

4135

2.05

63.25

2.6

4.3

9.89

19.77

ug/l

1.03

623

3394

(40760892) CBC W Ordered Manual Differential panel - Blood

1251

8000

1.81

61.25

5.6

4.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1255

8063

1.80

60.32

2.0

1.8

16238063.94

27945145.29

pmol/l

0.53

1010

6656

(3003327) Ova and parasites identified in Stool by Light microscopy

327

1245

2.77

59.69

1.9

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1231

7893

1.80

59.39

2.5

3.0

2.45

2.46

mmol/l

1.32

1098

7087

(3002179) Metamyelocytes/Leukocytes in Blood

645

3349

2.10

58.47

4.4

4.3

0.47

0.67

2.34

215

1021

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1110

6928

1.83

58.39

2.2

1.9

—

(3019225) pH of Specimen

699

3749

2.04

58.01

4.5

7.37

7.35

3.64

540

2666

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

375

1552

2.56

57.90

1.6

1.9

39.11

39.20

u/l

0.02

329

1355

(3021601) Nitrite [Presence] in Urine by Test strip

2499

19609

1.70

57.03

4.8

4.1

0.00

estimate

0.23

624

4225

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

617

3182

2.11

56.83

3.7

4.2

78.07

90.99

ng/l

3.20

536

2721

(3035350) Ketones [Presence] in Urine by Test strip

2521

19842

1.70

56.74

4.8

4.1

8.43

3.66

estimate

0.56

637

4331

(3009261) Glucose [Presence] in Urine by Test strip

2530

19973

1.70

55.89

4.9

4.1

0.01

0.08

estimate

0.53

603

4061

(3026782) Osmolality of Urine

1199

7763

1.77

55.20

3.5

3.0

507.13

532.77

mosm/kgh2o

3.77

1074

6826

(3025159) Blasts/Leukocytes in Blood

640

3388

2.05

54.81

4.8

4.7

0.10

0.18

0.40

186

883

(3009445) Proteinase 3 Ab [Units/volume] in Serum

381

1636

2.47

54.29

1.3

1.5

4.79

15.76

iu/ml

—

(3017181) Myelocytes/Leukocytes in Blood

653

3529

2.01

52.65

4.7

4.4

0.68

0.88

1.44

205

1100

(3021440) Promyelocytes/Leukocytes in Blood

632

3378

2.03

52.54

4.7

4.5

0.09

0.10

0.30

184

949

(3017732) Neutrophils [#/volume] in Blood

803

4663

1.90

52.37

3.3

4.43

4.74

e9/l

0.47

646

3989

(3020961) Endomysium IgA Ab [Titer] in Serum

388

1711

2.40

52.07

1.2

1.1

132.14

143.63

titre

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

430

1985

2.30

51.96

1.7

1.8

1.48

1.54

g/l

0.73

379

1721

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1699

12287

1.65

50.96

3.6

3.3

1542.09

1491.99

ng/l

0.17

1477

10697

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

431

2010

2.28

50.80

2.5

2.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

283

1096

2.70

49.81

2.1

1.6

0.23

g/l

0.41

273

1044

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

759

4394

1.89

49.71

2.7

2.9

8.52

8.55

umol/l

0.01

665

3862

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

453

2189

2.20

48.89

3.2

3.5

4.38

4.48

pmol/l

1.23

398

1936

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

285

1127

2.64

48.10

2.1

1.6

1.13

1.19

g/l

2.29

274

1073

(3015171) Extractable nuclear Ab [Units/volume] in Serum

324

1366

2.49

47.87

1.3

1.2

1.44

1.12

u/ml

0.11

111

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

288

1150

2.62

47.65

1.5

1.89

10.20

iu/ml

0.67

211

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3814

34676

2.45

47.57

25.9

17.6

23.04

25.20

mg/l

4.21

3316

28945

(44816559) Phosphatidylethanol [Mass/volume] in Blood

335

1449

2.43

46.80

1.8

1.6

0.34

0.31

mg/l

0.46

140

650

(3023420) DNA double strand Ab [Units/volume] in Serum

341

1488

2.41

46.71

2.1

1.7

12.77

6.47

iu/ml

1.59

336

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

559

2982

2.01

46.34

1.8

1.7

—

(3015736) pH of Urine

2043

15768

1.59

44.97

4.0

3.6

6.26

0.07

1102

8632

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

322

1393

2.42

44.92

1.3

1.2

—

(3023368) Bacteria identified in Blood by Culture

1534

11106

1.61

43.94

4.9

4.5

—

(3037756) Immunofixation for Serum or Plasma

231

866

2.77

43.23

1.5

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

530

2842

1.99

43.11

5.2

4.4

5.21

5.14

kpa

0.85

501

2722

(3009343) pH of Capillary blood

518

2766

2.00

42.61

5.2

4.4

7.41

7.42

1.26

436

2300

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

317

1395

2.38

42.52

3.1

2.6

—

(3026008) Bacteria identified in Urine by Culture

1661

12343

1.58

42.10

3.8

3.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

174

569

3.15

41.60

1.3

0.16

0.36

nmol/l

1.54

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

240

938

2.66

41.39

1.5

2.0

12.28

12.02

mg/l

0.16

216

864

(3002582) Erythrocytes [#/volume] in Urine

1719

12913

1.57

41.33

4.3

3.6

68.33

82.73

e6/l

0.25

1401

9902

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

568

3166

1.92

41.13

4.5

4.0

1.23

mmol/l

0.11

487

2747

(3029937) Albumin [Presence] in Urine by Test strip

1509

11039

1.58

40.48

4.9

4.3

0.00

estimate

1.74

588

3878

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

980

6458

1.68

40.15

1.4

1.3

31.77

33.69

iu/ml

0.17

277

1907

(3000850) Epithelial cells [#/volume] in Urine

1277

9007

1.61

39.85

3.2

2.8

4.65

5.58

e6/l

2.71

1169

8212

(3045424) Erythrocytes [Presence] in Urine

386

1896

2.14

39.67

2.4

2.2

0.00

0.45

estimate

0.53

106

585

(3024980) IgG subclass 4 [Mass/volume] in Serum

176

597

3.04

39.52

1.7

1.6

0.97

0.80

g/l

0.54

135

473

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

167

554

3.10

38.97

1.3

0.59

3.85

nmol/l

0.51

158

531

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

257

1073

2.49

38.64

1.6

1.4

7.20

12.17

iu/ml

—

(3018095) Leukocytes [#/volume] in Urine

1881

14564

1.54

38.61

5.1

4.2

123.31

104.86

e6/l

0.33

1457

10311

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

462

2462

1.99

38.01

4.9

4.3

1.81

1.83

mmol/l

0.05

341

1806

(3013005) Retinol [Moles/volume] in Serum or Plasma

183

4.78

37.83

1.9

1.8

1.80

1.92

umol/l

0.67

168

(3035637) Corticotropin [Mass/volume] in Plasma

155

503

3.16

37.54

1.4

1.6

22.88

28.10

ng/l

0.93

155

503

(3041096) Erythrocytes [Presence] in Urine by Automated

1415

10347

1.56

37.24

4.3

3.6

0.02

0.20

estimate

1.02

518

3325

(3044927) Protein electrophoresis panel - Urine

137

417

3.36

36.83

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

912

6037

1.66

36.20

1.4

1.3

15.23

12.46

u/ml

0.36

282

2234

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

222

892

2.57

36.16

1.1

11.91

6.15

eliau/ml

0.30

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

217

864

2.60

36.01

2.0

3.4

354.01

739.44

u/ml

0.60

186

791

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1869

14595

1.52

35.96

4.8

4.1

0.02

0.22

estimate

0.73

510

3462

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

314

1478

2.22

35.83

2.1

2.2

466.85

638.74

ug/l

0.44

291

1404

(3030467) Casts [#/volume] in Urine by Automated count

1501

11204

1.54

35.58

4.2

3.5

0.40

0.45

e6/l

0.28

1188

8293

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

810

5219

1.69

35.58

2.0

1.9

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

149

488

3.13

35.54

1.2

1.3

0.20

0.22

nmol/l

0.25

123

396

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

239

1004

2.47

35.44

1.4

1.2

3.13

3.25

u/ml

0.05

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1150

8114

1.58

34.92

2.1

1.8

1.24

1.37

mg/l

0.75

860

6281

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

246

1058

2.41

34.64

1.4

1.2

6.45

39.90

u/ml

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

211

845

2.58

34.60

1.4

1.2

1.88

6.65

u/ml

0.87

(3028192) IgG subclass 2 [Mass/volume] in Serum

122

359

3.47

34.59

1.4

3.03

2.93

g/l

0.24

270

(3027135) IgG subclass 1 [Mass/volume] in Serum

122

359

3.47

34.59

1.4

7.34

6.76

g/l

0.63

270

(3024139) IgG subclass 3 [Mass/volume] in Serum

122

359

3.47

34.59

1.4

0.43

0.41

g/l

0.28

269

(3013139) Helicobacter pylori Ag [Presence] in Stool

457

2506

1.93

34.43

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

237

1005

2.44

34.42

1.4

1.2

14.97

8.33

u/ml

0.56

143

(4062490) Immunoglobulin typing, IgG

121

357

3.46

34.17

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

310

1481

2.18

34.06

2.3

3.4

1336.72

3693.52

u/ml

0.60

260

1268

(3021589) Normoblasts [#/volume] in Blood

2065

16580

1.50

34.01

16.1

12.1

0.00

e9/l

1.64

1698

13467

(3017143) Hepatitis C virus Ab [Presence] in Serum

646

3966

1.75

33.67

1.5

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

443

2426

1.93

33.47

2.6

2.4

19.33

21.16

au/ml

0.22

217

(3019550) Sodium [Moles/volume] in Serum or Plasma

3818

35444

2.14

33.25

30.2

21.1

139.37

139.62

mmol/l

6.93

3763

34746

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

412

2225

1.95

32.41

1.3

53.05

55.28

au/ml

0.06

153

(3023103) Potassium [Moles/volume] in Serum or Plasma

3818

35498

2.11

32.24

30.4

21.3

3.98

mmol/l

0.35

3760

34742

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

163

600

2.79

31.56

1.2

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

217

4.03

30.49

1.4

1.6

4.98

7.14

u/l

1.77

193

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

137

471

2.97

30.07

1.3

—

nmol/l

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

612

3812

1.71

30.02

2.0

1.7

1.73

1.51

5.84

502

3312

(40758558) Short blood count panel - Blood

1491

11445

1.48

29.34

7.5

6.4

—

(3044640) Blood type and Crossmatch panel - Blood

1592

12404

1.46

28.89

2.9

2.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

247

1150

2.22

28.87

1.4

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

131

450

2.97

28.80

1.4

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

1288

9684

1.48

27.78

5.2

4.3

86.69

87.53

0.62

1258

9490

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3604

33168

1.72

27.53

6.0

5.4

5.92

5.98

mmol/l

1.78

3299

30212

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

140

512

2.80

27.46

1.3

1.1

57.20

10.71

u/ml

—

(3003181) Sodium [Moles/volume] in Urine

188

803

2.41

26.86

1.6

1.4

60.02

62.51

mmol/l

0.33

149

654

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

266

1318

2.09

26.51

1.5

1.6

26.54

18.43

u/ml

0.54

255

(3037121) Protein [Mass/volume] in Urine

277

1395

2.06

26.43

2.8

3.6

326.95

359.52

mg/l

0.20

126

618

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

216

987

2.25

26.41

1.5

1.6

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

288

1472

2.03

26.39

4.0

3.4

24.36

24.81

mmol/l

1.01

280

1449

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

718

4828

1.59

25.71

8.7

7.8

5.09

kpa

0.03

688

4644

(3027801) Oxygen [Partial pressure] in Arterial blood

718

4828

1.59

25.71

8.7

7.8

12.01

12.27

kpa

0.68

687

4644

(3045414) Leukocytes [Presence] in Urine

586

3760

1.65

25.39

2.4

2.2

0.02

0.01

estimate

0.33

124

774

(3007566) Smooth muscle Ab [Titer] in Serum

216

1010

2.20

24.97

1.2

83.75

88.82

titre

0.12

(3038026) Centromere Ab [Units/volume] in Serum

275

3.36

24.82

1.3

1.1

98.60

59.45

u/ml

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1041

7649

1.48

24.63

5.4

4.1

356.46

542.73

ng/l

0.48

804

6225

(3019977) pH of Arterial blood

712

4826

1.58

24.53

8.8

7.8

7.42

0.65

377

2632

(40761536) Microorganisms panel - Urine sediment

486

2998

1.70

24.40

5.0

4.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

293

1549

1.96

24.37

2.0

1.9

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

130

489

2.71

24.19

1.1

1.53

1.52

g/l

0.06

118

445

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

719

4913

1.56

23.85

2.1

1.9

—

(3003396) Base excess in Arterial blood by calculation

704

4794

1.57

23.69

8.7

7.8

1.01

0.93

mmol/l

0.17

599

3941

(3005322) IgE [Units/volume] in Serum or Plasma

393

2302

1.78

23.67

1.5

1.3

435.92

268.42

u/ml

0.45

373

2131

(3020779) Urea [Moles/volume] in Serum or Plasma

591

3871

1.62

23.44

8.3

7.7

10.12

10.16

mmol/l

0.05

563

3706

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3555

32883

1.61

23.18

23.9

17.3

80.75

78.59

ml/min/173m2

7.08

3346

30449

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

564

3681

1.62

22.65

3.1

2.5

33.80

52.88

u/l

0.82

473

3084

(3023183) Ammonium ion [Moles/volume] in Plasma

189

872

2.22

22.59

2.4

2.7

31.15

34.45

umol/l

1.15

165

781

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

128

496

2.63

22.49

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3512

32452

1.58

22.31

7.4

6.8

38.94

39.58

mmol/mol

3.98

3267

30178

(3022313) Gas panel - Capillary blood

344

1973

1.81

22.20

6.0

4.7

—

(3042936) Bacteria identified in Isolate by Culture

782

5521

1.51

22.17

2.3

2.0

—

(3034770) Mitochondria Ab [Titer] in Serum

208

1005

2.13

22.14

1.2

1201.00

1000.00

titre

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1234

9528

1.42

21.97

2.8

2.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

242

3.35

21.83

1.4

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

744

5219

1.52

21.69

1.6

1.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

289

1581

1.89

21.68

5.6

4.8

24.91

24.72

mmol/l

0.44

266

1468

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

160

701

2.33

21.62

1.3

1.2

217.78

340.00

titre

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

239

3.35

21.55

1.4

1.2

—

(3016502) Oxygen saturation in Arterial blood

636

4332

1.55

21.18

9.1

8.1

95.43

95.50

0.09

614

4183

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

425

2631

1.69

20.93

1.8

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2067

17489

1.37

20.87

3.1

2.9

—

estimate

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

265

1432

1.91

20.63

2.0

1.8

—

(3000012) Reticulocyte production index

144

615

2.39

20.62

2.0

2.2

0.82

0.89

0.77

419

(3018677) aPTT in Platelet poor plasma by Coagulation assay

852

6207

1.47

20.50

2.3

2.2

29.53

29.77

0.54

816

6038

(3009214) Lutropin [Units/volume] in Serum or Plasma

194

945

2.11

20.23

1.7

1.6

10.29

9.29

u/l

0.48

166

742

(3025941) Bacteria identified in Stool by Culture

323

1879

1.78

19.84

1.3

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

647

4485

1.53

19.78

5.1

35.40

33.02

5.57

455

2912

(3026493) Urate [Moles/volume] in Serum or Plasma

1245

9769

1.39

19.75

3.0

2.9

339.38

347.80

umol/l

1.71

1079

8525

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

130

542

2.44

19.64

2.4

2.2

32.72

32.39

0.41

130

537

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

302

2.96

19.48

1.1

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

124

509

2.48

19.38

4.8

5.2

353.75

351.86

umol/l

0.05

105

450

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

100

369

2.75

19.37

1.2

65.73

65.66

u/l

0.00

325

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3815

36214

1.78

19.18

17.1

12.7

23.52

25.49

u/l

7.04

3747

35085

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

113

446

2.58

19.17

1.1

4.30

2.54

eliau/ml

0.74

172

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

258

3.10

19.06

1.9

2.6

204.52

217.71

e6/l

0.26

216

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3845

36593

1.83

19.02

32.8

23.0

78.63

79.12

umol/l

0.29

3808

36143

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

198

996

2.04

18.95

1.9

2.0

3.55

9.77

iu/l

0.53

393

(3021447) Carbon dioxide [Partial pressure] in Venous blood

635

4422

1.52

18.94

4.7

4.2

5.96

5.81

kpa

3.30

612

4311

(3012544) pH of Venous blood

638

4469

1.51

18.47

4.7

4.3

7.37

7.38

0.87

379

2623

(3007853) Bacteria identified in Skin by Aerobe culture

647

4546

1.50

18.45

2.0

1.8

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

162

766

2.16

18.25

1.3

1.2

65.70

42.07

u/ml

0.91

(3000494) Fungus identified in Specimen by Culture

639

4491

1.50

18.18

1.7

1.5

—

(3042631) Mycobacterium sp identified in Specimen

126

537

2.39

18.16

3.1

2.8

—

(3014051) Protein [Presence] in Urine by Test strip

1306

10441

1.37

18.13

3.5

3.1

0.19

0.06

0.48

275

(3008295) Osmolality of Serum or Plasma

114

466

2.49

18.00

1.6

1.4

277.10

277.88

mosm/kgh2o

0.10

347

(1616796) Gas panel - Central venous blood

185

926

2.05

17.96

4.0

4.1

—

(3002032) Base excess in Venous blood by calculation

616

4307

1.51

17.95

4.7

4.2

2.06

1.78

mmol/l

1.12

544

3734

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

236

1291

1.88

17.69

1.4

1.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

551

3791

1.52

17.29

9.2

8.0

1.32

1.34

mmol/l

0.10

538

3724

(3002173) Hemoglobin [Mass/volume] in Arterial blood

576

4019

1.50

16.89

10.0

8.5

119.16

120.60

g/l

0.98

561

3925

(3035933) Granulocytes/Leukocytes in Blood

169

838

2.06

16.84

3.7

3.3

58.55

57.56

0.44

169

838

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

429

2810

1.59

16.74

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

257

2.95

16.69

1.7

2.5

515.38

523.65

e6/l

0.04

202

(3028626) Oxygen [Partial pressure] in Capillary blood

226

1244

1.86

16.62

5.3

4.4

8.28

8.35

kpa

0.28

220

1214

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

115

491

2.38

16.54

1.6

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

121

530

2.32

16.43

2.2

2.3

—

(3011412) CD3 cells [#/volume] in Blood

367

2.60

16.36

2.3

2.4

1321.06

1194.65

e6/l

0.52

316

(21494890) Protein electrophoresis panel - 24 hour Urine

101

409

2.51

16.30

1.6

2.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

223

1238

1.85

15.97

3.8

5.5

1.52

1.57

mg/l

0.40

205

1124

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

138

3.66

15.76

1.3

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

396

2582

1.59

15.73

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

107

4.05

15.66

1.3

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

109

466

2.38

15.65

1.6

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

138

652

2.16

15.62

1.6

1.9

5.19

4.75

mmol/24h

0.68

111

564

(3019150) Specific gravity of Urine by Refractometry

1100

8727

1.36

15.55

4.7

4.3

1.02

1.36

kg/l

0.80

778

5912

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

154

761

2.06

15.51

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

109

468

2.37

15.51

1.6

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

171

878

1.99

15.49

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

167

852

2.00

15.41

1.2

1.4

3.69

3.78

mmol/l

0.47

156

804

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

111

482

2.34

15.39

1.6

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

313

1936

1.67

15.37

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

282

1698

1.71

15.31

1.9

2.85

2.29

ug/l

0.24

233

1494

(3025468) Yersinia sp identified in Specimen by Organism specific culture

108

465

2.36

15.27

1.6

1.4

—

(3011288) Drugs identified in Urine by Screen method Nominal

165

842

2.00

15.22

2.8

2.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

165

842

2.00

15.22

1.4

1.6

316.73

1134.61

e6/l

1.29

139

653

(3023419) Bacteria identified in Sputum by Culture

121

550

2.24

15.08

2.6

—

(3009508) Creatinine [Moles/volume] in Urine

1595

13422

1.31

14.81

3.8

3.5

6.94

7.35

mmol/l

3.17

1321

11307

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

384

2522

1.58

14.77

11.1

9.8

24.33

24.22

mmol/l

0.23

371

2478

(3024522) Salmonella sp identified in Specimen by Organism specific culture

110

487

2.29

14.61

1.6

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

368

2399

1.59

14.61

10.7

10.3

15.84

15.89

0.15

353

2311

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

173

911

1.94

14.59

1.6

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

843

6472

1.38

14.51

4.0

3.3

3.55

2.40

e6/l

1.94

467

3195

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

207

3.03

14.49

1.3

1.2

25.31

19.51

u/l

0.61

174

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

415

2.39

14.40

4.1

3.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

161

834

1.97

14.25

1.3

1.6

30.69

33.20

e6/l

0.04

126

612

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

356

2317

1.59

14.22

1.2

120.26

136.45

u/ml

0.36

120

830

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

191

1049

1.86

14.18

1.7

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2328

20661

1.29

14.17

3.2

2.9

—

(3000991) Gas panel - Venous blood

532

3779

1.47

14.13

10.8

9.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

395

2.41

14.06

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

341

2.52

14.04

1.2

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

476

3312

1.49

14.02

3.8

3.1

218.83

211.38

ng/l

0.14

441

3037

(3024666) Lithium [Moles/volume] in Serum or Plasma

175

3.17

13.95

14.0

13.1

0.62

mmol/l

0.05

162

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

297

2.62

13.79

1.1

1.2

88.57

142.14

titre

—

(3017704) Immunofixation for Urine

224

2.89

13.78

1.5

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

194

1084

1.83

13.64

1.7

1.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

215

2.91

13.58

1.3

1.2

100.61

84.58

u/l

0.82

185

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

178

3.12

13.57

13.5

14.9

774.30

808.37

nmol/l

0.17

172

(3012501) Base excess in Blood by calculation

157

821

1.95

13.53

4.2

4.8

2.57

2.63

mmol/l

0.10

572

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

115

3.68

13.43

1.6

1.5

16.01

14.61

pmol/l

1.07

(3020191) Ethanol [Moles/volume] in Serum or Plasma

279

2.65

13.32

1.6

1.4

0.97

1.17

promille

0.56

220

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

144

736

1.99

13.26

1.3

297.75

253.81

u/ml

0.51

416

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

192

1080

1.82

13.21

1.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

126

3.52

13.18

1.6

3.1

1.50

1.62

ug/l

0.11

118

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

322

2084

1.59

13.17

1.6

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

176

967

1.86

13.07

1.3

1.5

477.51

577.53

mg/l

1.72

167

918

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

128

631

2.06

13.03

1.5

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3878

37397

1.69

12.87

39.9

27.1

39.03

40.10

11.87

3849

36952

(3007461) Platelets [#/volume] in Blood

3877

37388

1.69

12.82

39.0

26.6

250.04

248.49

e9/l

0.70

3827

36591

(3021387) Prolactin [Units/volume] in Serum or Plasma

194

1106

1.79

12.78

2.1

1.6

317.31

307.48

mu/l

0.13

179

995

(3047181) Lactate [Moles/volume] in Blood

208

1211

1.76

12.75

5.3

6.0

1.29

1.31

mmol/l

0.09

188

1064

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

148

775

1.94

12.72

1.5

1.4

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3877

37395

1.69

12.72

38.9

26.5

91.86

91.20

14.64

3848

36970

(3010813) Leukocytes [#/volume] in Blood

3877

37402

1.68

12.62

39.1

26.6

6.88

6.84

e9/l

0.31

3814

36463

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

546

3980

1.43

12.57

4.3

3.6

—

(3035941) MCH [Entitic mass]

3876

37394

1.68

12.56

38.9

26.5

30.45

30.32

4.16

3846

36968

(3000963) Hemoglobin [Mass/volume] in Blood

3877

37407

1.68

12.55

39.3

26.8

130.15

133.85

g/l

47.54

3851

36990

(3049717) Cytology report of Urine Cyto stain

247

1515

1.67

12.53

2.6

2.7

—

(3026361) Erythrocytes [#/volume] in Blood

3876

37397

1.68

12.52

39.0

26.6

4.31

4.45

e12/l

52.77

3810

36466

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

134

684

1.99

12.41

1.4

1.5

147.06

144.13

au/ml

0.10

218

(3011985) Renin [Units/volume] in Plasma

112

536

2.12

12.34

1.4

56.48

69.29

mu/l

0.24

100

477

(3030981) Hyaline casts [#/volume] in Urine by Automated count

461

3270

1.46

12.26

2.7

2.5

0.35

0.45

e6/l

0.69

434

3149

(3024354) Oxygen [Partial pressure] in Venous blood

515

3733

1.43

12.21

3.9

3.7

4.34

4.53

kpa

1.22

497

3634

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

287

2.54

12.10

2.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

196

2.88

12.10

4.0

4.1

—

(3017354) Segmented neutrophils/Leukocytes in Blood

430

2.24

12.04

3.3

3.6

57.38

57.26

0.02

370

(3008152) Bicarbonate [Moles/volume] in Arterial blood

369

2524

1.51

11.76

6.8

6.6

24.72

24.48

mmol/l

0.50

351

2411

(40768804) Tissue Pathology biopsy report

1672

14457

1.26

11.64

2.4

2.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

174

991

1.79

11.53

2.6

2.3

126.42

128.04

g/l

0.44

136

782

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

148

804

1.87

11.42

1.3

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

105

3.55

11.28

1.4

1.6

0.43

0.39

ug/l

0.21

(3006653) Thiamine [Moles/volume] in Blood

206

2.74

11.07

1.2

134.89

137.09

nmol/l

0.08

206

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

142

770

1.87

11.04

1.6

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

4.26

11.00

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

199

1195

1.70

10.96

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1499

12860

1.26

10.96

4.7

4.3

10.04

9.25

mg/mmol

0.26

937

8055

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

285

1876

1.56

10.84

5.2

5.1

1.76

1.58

1.97

272

1769

(3016650) Hepatitis A virus Ab [Presence] in Serum

117

600

1.98

10.74

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

875

7033

1.31

10.69

3.8

3.1

1.05

1.16

e6/l

0.35

501

3769

(3052851) Hemolysis interference index of Serum or Plasma

180

1059

1.73

10.68

3.5

2.81

1.81

index

0.56

537

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

287

2.43

10.65

1.1

1.0

279.35

292.28

mg/l

0.72

258

(3042111) Morphology [Interpretation] in Bone marrow Narrative

133

715

1.89

10.63

1.4

1.6

—

(4034850) Laboratory test

184

1091

1.72

10.62

11.7

11.2

—

(3004809) Band form neutrophils/Leukocytes in Blood

128

680

1.91

10.60

3.5

3.8

1.21

1.51

0.31

114

608

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

133

721

1.87

10.37

1.7

1.6

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

438

2.13

10.34

1.4

1.2

33.80

69.03

u/ml

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

143

3.03

10.21

1.3

2.3

1785.45

23153.14

u/ml

0.53

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

160

2.90

10.11

1.4

1.6

40.60

39.90

g/l

0.37

160

(3007930) Methemoglobin/Hemoglobin.total in Blood

261

1712

1.56

10.09

5.3

0.87

0.02

246

1613

(3023323) Follitropin [Units/volume] in Serum or Plasma

208

1294

1.64

10.03

1.7

1.5

24.33

26.06

iu/l

0.31

180

1073

(4027681) Cerebrospinal fluid IgG ratio and IgG index

200

2.67

10.01

1.3

1.2

0.53

0.56

ratio

0.34

110

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

172

2.81

9.99

5.0

2.7

90.05

148.90

umol/l

0.90

104

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.05

9.95

1.7

2.2

18.56

15.80

umol/l

0.56

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

278

2.40

9.93

1.3

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

269

2.40

9.69

1.2

1.1

40.32

41.33

mg/l

0.04

220

(1001926) Buprenorphine [Presence] in Urine by Screen method

163

960

1.73

9.67

2.1

1.8

—

(3016038) Potassium [Moles/volume] in Urine

288

2.35

9.65

1.4

1.2

27.05

36.25

mmol/l

3.31

253

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

486

2.02

9.55

2.5

2.1

15.30

22.00

mg/l

1.62

169

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

366

2.18

9.54

1.6

1.3

27.05

25.41

u/l

0.16

304

(3000060) B lymphocytes [#/volume] in Blood

123

3.11

9.47

1.4

2.7

0.36

0.22

e9/l

0.71

(3012516) Albumin [Mass/volume] in Urine

1456

12606

1.24

9.43

3.8

3.6

50.10

49.94

mg/l

0.01

930

8142

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

142

810

1.78

9.42

6.5

5.6

761.84

2487.76

iu/ml

0.41

112

(3018333) Ribosomal P Ab [Presence] in Serum

273

2.37

9.39

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

275

2.35

9.24

1.0

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

501

1.98

9.14

1.3

300.30

312.45

pmol/l

0.11

428

(3003129) Base excess in Capillary blood by calculation

467

2.01

9.12

3.4

2.3

-0.28

0.51

mmol/l

0.74

446

(3008757) Leukocyte morphology finding [Identifier] in Blood

413

2.08

9.11

3.0

4.1

—

(4198724) Urine methamphetamine measurement

126

3.03

9.10

1.7

1.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

449

2.03

8.99

1.7

1.5

0.27

0.33

nmol/l

0.82

346

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

336

2.19

8.98

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

262

2.35

8.83

1.1

274.14

274.59

mg/l

0.00

225

(3000475) Leukocytes [#/volume] in Synovial fluid

163

987

1.68

8.76

1.6

13788.60

12988.05

e6/l

0.08

110

681

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.67

8.71

1.0

1.1

0.78

0.70

umol/24h

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

145

853

1.73

8.67

1.6

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

290

2.26

8.63

1.2

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

456

2.00

8.63

2.5

5.5

6.53

7.43

mmol/l

2.50

388

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

112

612

1.85

8.58

1.1

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

291

2.25

8.57

1.2

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

304

2.22

8.55

1.2

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

116

3.03

8.41

1.6

1.4

267.17

316.59

nmol/24h

0.06

116

(3027273) Bicarbonate [Moles/volume] in Venous blood

272

1876

1.48

8.34

3.5

25.26

25.21

mmol/l

0.07

257

1813

(3017446) Testosterone [Moles/volume] in Serum or Plasma

391

2884

1.39

8.32

2.5

2.3

13.55

12.63

nmol/l

1.25

342

2563

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

195

2958

0.64

8.32

2.0

1.9

3.21

3.45

ratio

1.36

135

2300

(3026389) Candida sp identified in Specimen by Organism specific culture

512

1.92

8.28

1.7

1.3

—

(4035726) Immunohistochemistry procedure

442

3330

1.37

8.27

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

245

2.35

8.27

1.1

0.11

8.91

nmol/l

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

239

2.36

8.25

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

421

3153

1.37

8.17

2.3

2.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

360

2628

1.41

8.14

3.7

3.6

127.46

128.05

g/l

0.19

336

2554

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

285

2.23

8.12

1.3

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3553

34090

1.32

8.09

6.2

6.0

2.48

2.62

mmol/l

17.14

3270

31485

(21494434) Karyotype in Bone marrow

366

2.07

7.99

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

138

823

1.70

7.89

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

138

823

1.70

7.89

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1376

12015

1.22

7.85

5.7

5.9

2.42

3.40

ug/l

1.19

1232

10822

(40759836) Histone Ab [Presence] in Serum by Immunoblot

296

2.18

7.83

1.2

1.1

—

(3010503) CD19 cells [#/volume] in Blood

220

2.38

7.83

2.9

2.2

1536.13

135.17

e6/l

0.49

210

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3335

31772

1.27

7.79

4.6

4.4

1.18

1.27

mmol/l

11.44

3025

28929

(3045716) Anion gap in Serum or Plasma by calculation

440

1.95

7.71

3.5

3.3

11.16

10.54

mmol/l

0.59

435

(3038177) Helicobacter pylori Ab [Presence] in Serum

504

1.89

7.68

1.4

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

319

2.12

7.63

1.1

1.2

108.76

103.93

pmol/l

0.30

319

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

541

1.85

7.63

1.8

1.6

—

(3039000) Anion gap in Blood by calculation

139

841

1.68

7.55

6.3

7.0

10.74

11.31

mmol/l

1.13

125

749

(3018572) Chloride [Moles/volume] in Blood

139

842

1.67

7.51

6.3

7.0

105.05

105.18

mmol/l

0.10

125

750

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

170

2.55

7.49

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

175

1127

1.58

7.40

2.3

1.9

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

345

2.05

7.30

1.6

360.73

340.64

mu/l

0.19

276

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

445

3425

1.34

7.23

2.4

2.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

204

2.37

7.19

1.0

1.2

83.17

83.18

u/l

0.00

180

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3492

33529

1.28

7.16

5.6

5.2

4.41

4.53

mmol/l

9.65

3229

31097

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

174

2.49

7.15

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

174

2.49

7.15

1.3

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

321

2.07

7.14

1.8

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

122

724

1.71

7.14

1.6

1.2

25.84

38.65

u/l

1.08

113

627

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

295

2.12

7.10

1.2

1.3

2.01

2.20

mmol/l

0.40

276

(3000764) Benzodiazepines [Presence] in Urine

182

1198

1.54

7.01

2.3

1.9

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

385

1.97

7.00

1.1

—

2.78

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

251

2.21

6.99

1.4

1.3

—

(4015189) Microbial culture of sputum

3.06

6.88

2.2

2.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

523

1.82

6.88

1.6

2.0

28.53

23.06

ug/l

0.16

516

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

545

1.80

6.87

1.9

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

255

2.17

6.74

1.4

1.3

—

(3028300) Cannabinoids [Presence] in Urine

182

1210

1.53

6.71

2.4

1.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

172

1130

1.55

6.70

1.8

—

(3014007) Fractional oxyhemoglobin in Arterial blood

364

2750

1.36

6.69

12.4

9.8

93.93

93.87

0.06

364

2740

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

269

2.13

6.69

1.3

4.10

3.02

u/ml

0.13

165

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

205

2.31

6.66

1.0

1.2

19.26

26.10

u/l

0.73

179

(3033099) Centromere Ab [Titer] in Serum

3.26

6.54

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

285

2077

1.40

6.54

4.8

4.1

43.82

47.28

1.57

279

2046

(3023199) Leukocytes [#/volume] in Pleural fluid

525

1.79

6.51

1.5

1.4

1804.36

3507.58

e6/l

0.48

356

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

413

1.88

6.35

1.6

—

(3044889) 12 lead EKG panel

2650

24845

1.19

6.33

5.2

4.4

—

1684.00

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3461

33296

1.25

6.31

5.5

5.1

1.50

1.45

mmol/l

8.33

3179

30655

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

173

2.38

6.28

1.2

1.1

—

(3027008) Opiates [Presence] in Urine

179

1205

1.51

6.25

2.3

1.9

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

224

2.20

6.24

1.6

1.5

4.85

6.15

u/l

0.36

178

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

533

1.76

6.20

2.6

2.5

16.39

835.29

u/ml

0.88

524

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

142

2161

0.64

6.19

1.9

1.7

3.33

3.43

mmol/l

0.31

1505

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

208

2.23

6.03

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

154

1013

1.54

6.00

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

426

3351

1.30

5.92

2.5

2.4

7.27

7.23

ug/l

0.01

344

2943

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

373

1.89

5.92

1.2

1.5

—

(3036603) Volume of Urine

276

2.04

5.91

1.6

1889.82

1889.55

0.00

269

(3003434) Protein [Mass/volume] in Pleural fluid

101

602

1.69

5.88

1.4

1.5

32.42

32.07

g/l

0.08

540

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

304

1.99

5.87

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

3.29

5.85

1.2

1.8

37.34

39.98

pmol/l

0.07

(3014271) Vancomycin [Susceptibility]

198

2.24

5.84

3.2

2.9

—

(44790048) Parainfluenza type 2 nucleic acid detection

537

1.73

5.79

1.8

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

537

1.73

5.79

1.8

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

537

1.73

5.79

1.8

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

537

1.73

5.79

1.8

1.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

493

1.76

5.76

2.1

2.0

88.65

89.48

0.38

486

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

119

745

1.62

5.74

2.5

1.9

203.56

199.79

pmol/l

0.15

112

699

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

3.47

5.72

3.1

3.3

64.72

20.54

mg/l

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

181

2.28

5.70

1.2

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

181

2.28

5.70

1.2

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

181

2.28

5.70

1.2

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

181

2.28

5.70

1.2

1.6

—

(21494755) Public health laboratory ask at order entry panel

154

2261

0.67

5.65

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

379

1.86

5.65

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

711

5976

1.23

5.65

1.7

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

122

772

1.60

5.64

1.5

1.7

0.77

0.85

nmol/l

0.55

106

643

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

3.71

5.64

1.1

1.0

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

3.71

5.64

1.9

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

153

1023

1.51

5.56

1.2

—

(3027944) Amphetamines [Presence] in Urine

174

1195

1.48

5.55

2.2

1.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

464

1.76

5.46

1.5

1.4

56555.30

87283.37

e6/l

0.50

251

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

150

1003

1.51

5.45

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

586

1.67

5.41

1.7

1.6

—

(3017569) Oxygen content in Arterial blood

245

2.05

5.39

2.9

2.2

14.10

16.33

4.13

245

(3002256) Pathology report gross observation

605

5026

1.24

5.35

1.4

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

139

919

1.53

5.33

1.1

1.2

—

(3012441) Differential panel - Pleural fluid

453

1.76

5.32

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

164

1124

1.48

5.30

2.8

2.2

7880.83

5698.58

u/l

0.27

441

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

323

1.90

5.30

1.2

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

323

1.90

5.30

1.2

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

323

1.90

5.30

1.2

1.5

—

(3045142) Bone marrow Pathology biopsy report

471

1.73

5.20

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

132

2.44

5.20

1.9

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

297

1.93

5.20

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

506

1.69

5.03

2.3

0.82

1.33

g/24h

1.87

292

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

338

1.85

4.95

1.1

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

367

1.81

4.95

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

389

1.79

4.94

2.2

2.4

39.24

35.19

iu/ml

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

151

1034

1.48

4.93

1.7

1.4

—

(3022621) pH of Urine by Test strip

381

3030

1.28

4.89

3.0

2.8

6.10

6.08

0.16

240

2096

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

157

1086

1.46

4.87

3.0

2.8

201.48

192.78

0.49

145

1040

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

112

2.51

4.87

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

101

2.58

4.79

1.1

14.96

17.11

umol/l

0.99

(3006270) Folate [Moles/volume] in Blood

313

1.87

4.79

1.3

1.2

321.15

361.23

nmol/l

0.78

268

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

119

2.45

4.79

1.0

1.2

4.99

11.92

pmol/l

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

133

897

1.50

4.69

3.4

0.82

nmol/l

0.00

109

722

(4146454) Self-monitoring of blood glucose

434

1.72

4.65

3.1

2.7

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.34

4.60

1.2

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

134

2.32

4.58

1.2

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

134

2.32

4.58

1.2

1.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

102

654

1.57

4.54

4.1

3.4

122.57

1559.33

u/ml

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

283

2187

1.32

4.52

3.9

3.2

0.66

0.62

1.21

283

2177

(3047189) Immunofixation for 24 hour Urine

187

2.10

4.51

1.5

1.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

409

1.72

4.47

1.3

1.4

350.14

351.00

u/l

0.00

391

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.77

4.44

1.3

1.2

0.64

3.09

mmol/l

1.34

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

166

1183

1.42

4.42

3.0

2.8

3.52

3.54

g/l

0.07

158

1126

(3023511) Choriogonadotropin [Units/volume] in Urine

556

1.61

4.42

1.4

1.3

—

(4024509) Urine culture

247

1880

1.33

4.39

2.1

2.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

5.01

4.31

1.3

1.1

36.00

115.32

u/l

—

(3016018) Differential panel - Cerebral spinal fluid

429

1.69

4.30

1.3

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

232

1.95

4.29

1.6

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

232

1.95

4.29

1.6

1.7

—

(37208534) Antinuclear antibody arbitrary concentration in serum

120

2.34

4.24

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

114

2.38

4.22

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

114

2.38

4.22

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

114

2.38

4.22

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

114

2.38

4.22

1.1

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.63

4.22

1.3

1.85

1.67

mmol/l

0.22

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

335

1.77

4.18

1.8

1.6

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

235

1.93

4.15

1.9

1.5

83.98

84.13

umol/l

0.01

235

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

141

989

1.44

4.12

1.4

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

135

2.23

4.08

1.2

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

188

2.03

4.08

1.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

162

2.11

4.03

1.2

1.4

138.65

157.71

mmol/24h

0.82

162

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

112

2.33

3.91

1.1

1.2

98.00

87.75

0.93

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.07

3.89

1.3

—

(3028717) Thiamine [Mass/volume] in Blood

2.89

3.89

1.1

1.3

66.18

66.46

ug/l

0.02

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.57

3.88

1.2

1.1

379.62

275.22

pmol/l

0.30

(3027923) C peptide [Moles/volume] in Serum or Plasma

213

1.93

3.86

1.8

1.4

1.23

1.21

nmol/l

0.01

156

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

113

2.31

3.84

1.1

1.4

101.08

85.35

1.02

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.30

3.81

1.6

5.07

1.55

mg/l

—

(37021550) Renin [Units/volume] in Plasma --upright

2.61

3.80

1.2

1.4

57.91

54.54

mu/l

0.04

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

113

774

1.47

3.77

1.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

377

3092

1.24

3.77

1.7

1.8

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

127

2.21

3.76

1.2

1.3

141.38

121.84

nmol/l

0.30

(3042517) Benzodiazepines panel - Urine

4.59

3.74

3.1

2.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

147

2.12

3.74

1.1

256.17

356.59

ng/l

—

(3045788) Cell count panel - Pleural fluid

439

1.63

3.73

1.5

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

942

0.60

3.68

1.1

1.49

1.52

g/l

0.46

942

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.61

3.63

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

247

1.83

3.61

1.9

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

160

1177

1.37

3.61

2.8

2.6

93.08

91.48

0.39

153

1147

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

366

3007

1.24

3.61

3.5

2.8

65.28

63.80

ml/min/173m2

0.30

174

1314

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

413

1.63

3.58

1.3

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

191

1.95

3.57

1.0

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2988

28763

1.14

3.55

31.2

21.7

13.84

13.70

5.66

2963

28376

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

278

1.77

3.54

1.1

1.0

52.88

42.79

ng/l

0.40

182

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

206

1.90

3.52

1.4

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

199

1.92

3.52

1.2

1.1

1.16

u/l

0.00

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.24

3.50

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

279

1.77

3.50

1.1

1.0

703.34

684.19

ng/l

0.10

181

(40768443) Skin Pathology biopsy report

219

1697

1.31

3.50

1.3

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

138

2.11

3.48

1.2

1.3

—

0.24

g/l

—

(3036489) Thrombin time

187

1419

1.33

3.46

2.4

2.3

20.60

21.29

1.27

167

1286

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.08

3.39

1.5

1.6

1.98

3.42

mg/l

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

228

1787

1.29

3.35

2.7

3.8

82.79

78.87

u/ml

0.04

217

1719

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

128

921

1.40

3.32

1.3

1.1

2.43

4.30

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.43

3.30

2.5

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

211

1.86

3.30

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

277

1.74

3.29

1.1

1.0

300.13

313.32

ng/l

0.14

185

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

277

1.74

3.29

1.8

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

2.54

3.29

1.6

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

255

1.77

3.29

1.9

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

254

2028

1.27

3.24

2.5

2.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

3.34

3.22

1.1

0.00

0.07

u/ml

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.58

3.21

1.1

2.4

—

10200.00

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

123

2.12

3.19

1.0

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.54

3.19

1.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

480

1.53

3.03

1.1

1.2

111.00

113.61

0.24

437

(3023410) Appearance of Cerebral spinal fluid

393

1.59

3.02

1.4

1.9

—

(21494814) CD8 cells/Lymphocytes in Specimen

147

1.98

2.99

3.4

2.0

29.76

30.30

0.06

147

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

498

1.52

2.98

1.1

—

(40768806) Pleura Pathology biopsy report

442

1.55

2.97

1.5

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.41

2.96

1.2

1.6

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

372

1.59

2.94

1.1

1.2

93.39

94.81

0.13

352

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

372

1.59

2.94

2.2

2.9

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

220

1.78

2.93

2.3

2.6

38.46

39.23

0.08

121

(40757373) Influenza virus identified in Isolate

2.32

2.91

1.7

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.44

2.89

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

320

1.63

2.87

3.5

3.1

9.58

31.73

mg/l

2.55

245

(40768446) Kidney Pathology biopsy report

150

1.94

2.84

1.8

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.40

2.79

1.2

1.5

1.60

2.60

u/ml

0.22

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.92

2.77

1.1

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

2.27

2.76

1.9

—

(3042951) Complement C1q Ab [Units/volume] in Serum

5.01

2.72

1.0

1.1

—

17.74

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.45

2.69

1.0

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.22

2.67

2.4

3.6

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

430

1.52

2.66

1.9

1.6

61.52

59.66

0.14

265

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

161

1.87

2.66

2.6

2.3

44.75

52.67

umol/l

0.67

138

(3044242) Glucose [Moles/volume] in Arterial blood

250

1.69

2.65

3.4

2.0

7.70

8.32

mmol/l

0.56

250

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

596

1.44

2.62

1.2

1.1

1686.75

1034.95

iu/ml

0.14

130

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

191

1.79

2.62

2.7

2.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.26

2.60

2.6

2.4

6.52

7.89

mmol/l

1.25

(3030313) Adrenal Ab [Titer] in Serum

3.61

2.57

1.4

1.1

—

(3042733) HLA Ab [Presence] in Serum

107

2.06

2.56

4.2

4.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.06

2.56

1.0

1.1

0.04

0.30

u/ml

0.73

(3004451) EKG impression Narrative

245

1.68

2.56

1.2

1.3

—

(3016228) CD19 cells/cells in Blood

149

1.89

2.55

3.3

2.0

12.75

7.46

0.66

142

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

128

1.96

2.55

1.2

0.29

0.30

g/l

0.21

103

(4195642) Thrombophilia screening test

468

1.48

2.53

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

519

1.45

2.49

1.2

1.3

3.89

5.32

u/ml

0.64

238

(3024928) Oxygen saturation in Venous blood

141

1086

1.31

2.45

3.8

58.79

61.06

0.57

135

1058

(3028433) Virus identified in Specimen by Culture

123

1.96

2.45

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

127

964

1.33

2.45

1.3

213.27

227.22

miu/ml

0.16

427

(3004716) Salmonella sp identified in Stool by Organism specific culture

206

1665

1.25

2.44

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.55

2.44

1.8

1.7

—

(1761868) Lipid panel - Serum or Plasma

1116

12053

0.90

2.44

3.6

3.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

531

1.44

2.41

1.2

1.3

3.12

3.58

u/ml

0.09

194

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1563

14710

1.10

2.34

2.0

1.9

1.22

1.33

mmol/l

6.50

1256

12318

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

120

912

1.33

2.31

1.3

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.18

2.30

1.1

1.2

0.11

24.54

u/ml

1.57

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.95

2.28

1.8

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.28

2.24

1.2

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

135

1.86

2.21

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

5.56

2.21

1.6

1.3

24.63

37.57

umol/24h

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

2.41

2.19

1.4

1.3

6.07

4.17

nmol/l

0.49

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

188

1.71

2.16

1.2

1.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

173

1.74

2.16

6.4

5.2

76.54

64.25

mg/l

0.62

125

(3003329) Lymphocytes/Leukocytes in Synovial fluid

337

1.52

2.16

1.6

1.5

27.80

30.80

0.25

204

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.00

2.10

1.3

1.1

—

(3035880) pH of Pleural fluid

236

1.62

2.10

1.2

1.4

7.43

7.41

0.33

160

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.56

2.07

1.1

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.91

2.07

1.2

1.3

—

(40758292) HTLV I+II Ab panel - Serum

2.18

2.04

1.1

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

130

1019

1.28

2.04

3.8

3.2

1.46

1.60

mmol/l

1.41

122

990

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

576

1.38

2.02

7.1

6.4

12.28

12.24

mg/l

0.03

538

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

247

1.58

2.00

1.4

1.9

79.43

119.13

ng/l

2.85

247

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

140

1.79

2.00

1.8

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

104

1.93

2.00

1.0

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.34

1.96

1.0

10.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.94

1.95

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.57

1.94

1.0

1.2

1.70

1.79

umol/24h

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

206

1715

1.21

1.91

2.4

2.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

113

1.86

1.91

1.1

1.2

2.57

38.49

u/ml

0.65

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

106

1.89

1.90

1.0

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

439

1.42

1.90

1.4

6.07

6.34

mmol/l

0.29

416

(3019230) Fractional oxyhemoglobin in Venous blood

119

932

1.29

1.90

3.6

3.5

61.05

61.45

0.07

119

926

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

267

1.54

1.89

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

292

1.51

1.87

1.5

1.8

—

(3022689) Creatine [Moles/volume] in Urine

114

1.85

1.87

1.2

1.4

7.17

7.73

mmol/l

0.28

114

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

611

1.35

1.86

1.1

20.44

20.71

au/ml

0.01

124

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.17

1.82

1.0

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.06

1.80

1.5

2.1

1.12

1.70

mmol/l

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

123

1.79

1.2

833.33

952.00

titre

—

(3044009) aPTT.lupus sensitive (LA screen)

2.76

1.79

1.1

1.2

—

(40768800) Prostate Pathology biopsy report

839

0.72

1.76

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

102

1.87

1.76

1.1

1.2

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

3.34

1.74

1.0

1.1

1.17

1.00

u/field

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

162

1.67

1.74

1.2

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

363

1.44

1.74

1.6

1.3

85373.92

120228.86

e6/l

0.19

246

(3019174) dRVVT (LA screen)

2.67

1.72

1.1

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

270

0.52

1.72

1.1

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

148

1.69

1.70

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

118

1.78

1.70

3.8

2.0

1.70

1.73

ratio

0.03

111

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

111

1.81

1.68

1.0

1.1

—

(3016750) Collection duration of Urine

211

1.57

1.67

2.1

495.84

497.62

min

0.03

153

(3008898) HLA-B27 [Presence]

135

1094

1.24

1.66

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

188

1.60

1.65

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2779

28500

0.92

1.64

32.6

22.7

331.19

331.94

g/l

4.29

2768

28332

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.03

1.64

1.2

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

181

1.61

1.63

1.4

1.3

5.50

5.90

mmol/l

1.18

173

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

105

1.81

1.62

1.0

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

122

983

1.25

1.59

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.33

1.58

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.20

1.56

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.28

1.55

1.6

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1028

9652

1.09

1.53

4.7

4.8

21.75

22.04

0.25

512

4967

(40757494) Bilirubin.total [Moles/volume] in Blood

208

1.54

1.53

1.9

2.7

9.18

59.96

umol/l

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

390

1.39

1.53

1.8

1.5

—

(4268621) Lupus anticoagulant assay

382

1.39

1.52

2.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

135

1108

1.23

1.50

2.0

1.7

—

30.85

—

(40768441) Liver Pathology biopsy report

260

1.47

1.45

1.2

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.37

1.45

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

203

1.53

1.45

2.6

2.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

288

3265

0.87

1.44

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

102

1.77

1.44

1.8

1.5

7.83

8.86

ug/l

0.75

102

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.12

1.44

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.12

1.44

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.12

1.44

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.92

1.43

1.0

1.4

—

(3000330) Specific gravity of Urine by Test strip

234

2030

1.16

1.42

3.8

3.5

1.02

ratio

0.89

206

1837

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

104

1283

0.81

1.39

1.7

1.6

1095.48

982.64

mu/l

0.63

1103

(3034274) Bile acid [Moles/volume] in Serum --fasting

424

1.35

1.38

1.6

2.2

5.42

8.77

umol/l

1.07

307

(3003694) ABO and Rh group [Type] in Blood

1097

10373

1.08

1.37

1.5

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.13

1.33

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.91

1.33

1.1

1.3

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

136

1.62

1.32

1.5

2.4

23.66

79.45

ug/l

0.48

123

(3014148) Varicella zoster virus Ab [Titer] in Serum

446

1.33

1.30

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

478

4367

1.11

1.30

7.8

7.2

—

(3051611) Lipemic interference index of Serum or Plasma

386

1.35

1.29

3.2

3.5

12.70

12.65

index

0.01

217

(3034092) Cytoplasmic Ig cells/cells in Blood

2.36

1.29

22.6

10.7

0.19

0.21

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.36

1.29

1.9

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.36

1.29

1.1

1.2

7.88

12.62

u/l

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

482

1.31

1.28

1.2

1.1

2.08

3.57

—

(3006576) Bicarbonate [Moles/volume] in Blood

122

1.64

1.27

5.4

7.2

24.49

24.87

mmol/l

0.20

110

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.79

1.27

1.7

2.4

3.13

411.59

ug/l

0.64

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.79

1.27

1.0

1.4

1.19

1.17

mmol/l

0.45

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

130

1.62

1.26

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.40

1.24

1.2

1.0

76.48

9.26

u/ml

—

(40762887) Creatinine [Moles/volume] in Blood

2.40

1.24

1.7

1.6

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.40

1.24

2.3

4.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

539

0.72

1.24

1.4

1.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.97

1.22

1.0

1.2

—

(44813793) Dust mix specific IgE antibody measurement

229

1.44

1.21

1.1

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

383

1.34

1.19

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.31

1.18

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.31

1.18

1.0

—

(4211845) Urine protein measurement

189

1.48

1.18

2.9

3.6

—

(3020650) Glucose [Presence] in Urine

125

1.60

1.17

2.8

1.9

0.00

0.05

estimate

0.80

125

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

141

1.56

1.17

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.93

1.17

1.6

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

790

0.78

1.14

4.2

3.6

24.32

28.74

mg/l

0.48

563

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

2.26

1.10

1.4

1.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.26

1.10

1.7

2.7

—

(3006462) Nitrate [Presence] in Urine

176

1.48

1.10

3.0

3.6

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.67

1.10

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

549

0.74

1.10

1.6

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

862

0.80

1.09

1.3

1.5

—

(3020491) Glucose [Moles/volume] in Blood

260

1.39

1.09

2.0

6.84

6.77

mmol/l

0.06

177

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.38

1.09

1.2

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

559

0.75

1.08

1.7

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

849

0.80

1.07

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

160

1385

1.16

1.06

4.1

3.2

0.29

0.35

iu/ml

2.28

762

(3001964) Herpes simplex virus Ag [Presence] in Specimen

105

1.62

1.06

2.1

1.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.12

1.05

2.4

4.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.67

1.04

2.5

1.8

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.27

1.03

10.8

7.8

100.80

101.32

g/l

—

(3010937) Rubella virus Ab [Presence] in Serum

2.27

1.03

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.96

1.03

1.9

1.5

52.67

43.28

umol/l

—

(3038515) Glucose [Moles/volume] in Venous blood

101

844

1.20

1.02

3.8

3.4

7.28

7.57

mmol/l

0.48

821

(40765096) Chromosome analysis panel by Banding

130

1.54

1.02

1.3

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

730

0.79

1.00

1.6

1.5

72.13

60.73

ug/l

1.16

625

(3024932) HLA-DR beta [Type]

1.62

0.99

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

115

1.57

0.99

1.2

1.4

11.04

13.28

g/l

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

673

0.78

0.98

1.5

0.91

0.95

ratio

0.51

414

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

673

0.78

0.98

1.5

1.13

1.19

ratio

0.20

416

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.84

0.98

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

538

0.76

0.98

1.6

1.5

1.31

1.27

0.19

391

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

672

0.79

0.97

1.5

1.13

1.14

ratio

0.03

413

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

459

1.27

0.97

1.1

—

(3004775) Volume in Urine collected for unspecified duration

292

1.34

0.97

2.1

2.3

736.19

639.71

0.51

186

(3050794) Legionella sp Ab [Presence] in Serum

1.95

0.97

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.89

0.94

2.4

2.8

0.64

ug/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.82

0.92

1.8

1.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.14

0.91

1.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.14

0.91

1.2

1.1

—

(40768795) Lymph node Pathology biopsy report

357

1.29

0.91

1.4

1.2

—

(3024471) HLA-A [Type]

102

1.57

0.90

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

662

0.80

0.88

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

1.79

0.87

1.2

1.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.86

0.87

1.0

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

2.00

0.87

2.3

1.8

40.69

22.26

u/ml

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

170

1.41

0.85

1.0

1.1

1678.71

1575.92

miu/ml

0.19

170

(3047007) Chlamydophila sp Ab [Presence] in Serum

489

1.23

0.82

1.4

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.88

0.81

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

337

1.28

0.81

1.7

1.6

16.38

24.00

u/ml

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

719

1.19

0.80

1.2

2.80

2.25

u/ml

0.15

407

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.76

0.0

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

133

1.43

0.73

2.4

2.5

0.60

0.61

mmol/l

0.27

133

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

176

1.37

0.72

1.1

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.80

0.72

1.1

1.0

—

(3014891) Appearance of Pleural fluid

1.58

0.71

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

109

1.47

0.70

1.9

1.8

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.92

0.70

1.2

1.0

—

(4212803) Bone marrow aspirate examination

1.71

0.70

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

127

1.42

0.67

3.6

2.8

28.32

30.47

umol/l

0.34

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

321

1.25

0.66

4.2

5.2

27.59

48.23

u/ml

0.89

(3020874) Milk IgE Ab [Units/volume] in Serum

206

1.31

0.65

1.4

1.2

6.32

3.03

u/ml

0.22

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.72

0.64

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.52

0.62

2.7

2.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

121

1.41

0.62

3.9

2.6

5.78

4.88

kpa

0.90

121

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

121

1.41

0.62

3.9

2.6

10.14

10.10

kpa

0.03

121

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

226

1.29

0.61

3.3

1.8

—

(3036670) Protein [Mass/volume] in Synovial fluid

122

1.40

0.60

1.2

33.13

40.12

g/l

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.51

0.58

1.0

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.67

0.56

1.2

5.82

5.94

mmol/l

—

(1002224) Polysomnography panel

122

1355

0.90

0.56

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.58

0.54

1.0

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.42

0.54

1.0

1.1

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

160

1.31

0.53

1.3

1.5

60.93

67.14

0.27

128

(3014599) Egg white IgE Ab [Units/volume] in Serum

196

1.28

0.52

1.4

1.2

64.31

17.34

u/ml

0.36

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

884

1.12

0.52

2.7

2.3

99.02

99.63

ug/min

0.01

531

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.47

0.50

3.0

2.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

236

0.76

0.50

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

456

1.16

0.48

1.1

4.93

6.31

u/ml

0.16

222

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.41

0.46

1.4

1.2

—

(3002619) Bacteria identified in Specimen by Culture

1.38

0.46

1.3

1.1

—

(3044007) Cell count panel - Peritoneal fluid

120

0.67

0.45

1.5

1.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

237

1.23

0.45

1.1

17.95

16.12

u/ml

0.16

(3010726) Horse dander IgE Ab [Units/volume] in Serum

581

1.14

0.45

1.1

1.95

1.58

u/ml

0.12

323

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.40

0.45

1.0

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

104

1.35

0.43

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

359

1.17

0.42

1.3

1.6

2.70

4.12

ug/l

0.99

316

(40765089) Chromosome analysis panel - Blood by G-banded

0.63

0.42

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

314

1.18

0.41

2.5

2.8

22.68

31.47

mg/l

1.12

229

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.40

0.0

1.1

—

0.18

—

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.39

0.0

1.2

—

0.02

—

(1761482) Bacteria [#/volume] in Urine by Culture

104

951

1.10

0.39

4.9

4.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

187

1.23

0.39

1.6

1.7

7.78

3.20

u/field

0.38

134

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.35

0.37

1.6

1.1

96.00

90.81

titre

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

207

1.21

0.36

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.27

0.36

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.31

0.35

2.8

7.3

64.75

72.57

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.36

0.34

1.3

3.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.36

0.34

3.7

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

371

0.86

0.33

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

164

1.22

0.32

1.1

0.20

2.73

u/ml

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.33

0.32

1.4

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

193

1.19

0.30

1.4

1.6

7.83

7.79

mmol/l

0.03

186

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

106

0.75

0.29

13.3

8.0

5.86

5.97

kpa

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.23

0.29

8.1

12.9

5.34

5.68

mmol/l

—

(3024263) Appearance of Synovial fluid

204

1.18

0.28

1.7

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

183

0.82

0.27

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

507

4933

1.03

0.26

1.5

—

(3025130) Human papilloma virus identified in Specimen

436

1.10

0.24

1.3

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.71

0.24

1.0

68.12

37.07

iu/ml

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.25

0.22

1.1

1.3

—

(44806071) Cardiolipin IgM antibody measurement

1.22

0.22

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

5.89

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

5.5

—

400.25

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.01

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

439

0.91

0.20

1.2

1.1

0.09

0.39

u/ml

1.13

170

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.20

0.0

1.1

—

18.13

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

490

1.08

0.20

1.2

1.1

5.22

4.71

u/ml

0.07

263

(3041354) Potassium [Moles/volume] in Venous blood

464

1.08

0.17

2.9

2.4

4.05

4.07

mmol/l

0.12

459

(3035285) Chloride [Moles/volume] in Venous blood

464

1.08

0.17

2.9

2.4

106.08

105.29

mmol/l

0.51

459

(3023487) Leukocytes [#/volume] in Peritoneal fluid

142

0.84

0.17

1.3

2.2

1896.14

939.17

e6/l

—

102

(40768793) Breast Pathology biopsy report

886

0.95

0.17

1.4

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

256

0.90

0.16

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

555

0.94

0.15

1.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

192

0.88

0.14

2.0

3.5

1.59

1.09

0.57

192

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

721

7114

1.02

0.14

3.5

3.4

0.73

0.81

ug/l

1.28

533

4898

(3003888) Timothy IgE Ab [Units/volume] in Serum

635

1.06

0.14

1.1

3.45

4.79

u/ml

0.64

362

(3041806) Other cells [#/volume] in Blood by Manual count

0.82

0.13

2.0

1.6

0.54

0.48

e9/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

134

1296

1.04

0.13

1.6

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

453

1.06

0.12

3.0

2.4

1.21

1.20

mmol/l

0.53

448

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

308

1.07

0.11

1.8

2.2

1.29

1.42

u/field

0.10

161

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

105

1.14

0.11

2.5

2.6

9.03

9.66

mg/l

0.16

(3001893) Eosinophils/Leukocytes in Pleural fluid

134

1.12

0.10

1.2

1.5

1.60

2.76

—

114

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.11

0.09

1.0

1.2

—

(44806420) Estimation of glomerular filtration rate

340

0.94

0.09

2.3

2.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

206

0.92

0.08

1.7

1.4

203.58

204.86

pmol/l

0.01

206

(3034426) Prothrombin time (PT)

107

1.12

0.08

1.0

1.3

27.92

28.02

0.04

107

(3002523) Influenza virus A Ag [Presence] in Specimen

548

1.04

0.08

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

146

1.10

0.08

1.3

1.2

13.13

9.91

mm/h

0.29

146

(3003740) Influenza virus B Ag [Presence] in Specimen

549

1.04

0.08

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

1.03

0.07

5.7

2.5

14.41

15.07

ml/dl

—

(4133840) Spirometry

0.81

0.07

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.85

0.06

13.1

8.2

6.52

5.34

kpa

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

484

0.97

0.04

1.7

1.6

67.31

58.34

ug/l

0.49

484

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

111

1127

0.98

0.04

1.5

1.7

8.30

4.78

mg/l

0.64

839

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

270

0.96

0.03

1.2

1.1

14.12

10.00

iu/ml

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

400

1.03

0.02

1.5

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

281

1.03

0.02

1.3

1.4

—

60.53

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

609

0.99

0.02

1.8

1.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

623

1.01

0.01

1.1

0.85

1.30

u/ml

0.43

295

(3036071) Salmonella sp Ab [Titer] in Serum

112

0.98

0.00

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

161

0.99

0.00

1.6

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

201

1.00

0.00

7.0

6.9

20.74

110.94

ug/l

0.51

123

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

100

1004

1.00

0.00

1.5

1.4

—

(4281824) Cell count and differential, peritoneal fluid

374

0.99

0.00

1.1

1.2

—

(3013727) Leukocytes other/Leukocytes in Blood

133

0.98

0.00

2.5

4.1

49.19

54.32

0.31

126

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.0

—

30.72

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(3021374) Sirolimus [Mass/volume] in Blood

0.00

0.0

6.5

—

6.37

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

26.75

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.95

0.00

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.00

0.00

2.7

3.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

3220.00

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

40.60

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

28.77

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

4.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.02

-0.00

1.0

1.1

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

1.44

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

2.90

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

371.63

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_ABNORMAL_WEIGHT_LOSS – Abnormal weight loss

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Abnormal weight loss

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Abnormal weight loss (R18_ABNORMAL_WEIGHT_LOSS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints